	Target node	HUGO names	Interaction type	Source	Description	Reference: PMID	Logical rule
0	Acidosis	input	input	0/1	Input of the model		(Acidosis)
1	AKT	AKT1, AKT2, AKT3	+	HSPs	Hsp90 plays an important role in maintaining Akt kinase activity by binding Akt and preventing PP2A-mediated dephosphorylation	10995457	((HSPs | (PDK1 & PIP3) | PIP3 | (SHH & PIP3)) & !PTCH1)
2	AKT	AKT1, AKT2, AKT3	+	PDK1	From Fumia et al, 2013	23922675	((HSPs | (PDK1 & PIP3) | PIP3 | (SHH & PIP3)) & !PTCH1)
3	AKT	AKT1, AKT2, AKT3	+	PIP3	From Fumia et al, 2013	23922675	((HSPs | (PDK1 & PIP3) | PIP3 | (SHH & PIP3)) & !PTCH1)
4	AKT	AKT1, AKT2, AKT3	-	PTCH1	Most importantly, we report that shh induces mapk/erk and phosphoinositide 3-kinase (pi3k)-dependent akt phosphorylation and that activation of both signaling pathways is essential for shh's signaling in muscle cells. However, the effect of shh on akt phosphorylation is more robust than that on mapk/erk, and data suggest that shh influences these pathways in a manner similar to igf-i.	17688959	((HSPs | (PDK1 & PIP3) | PIP3 | (SHH & PIP3)) & !PTCH1)
5	AKT	AKT1, AKT2, AKT3	+	SHH	Most importantly, we report that shh induces mapk/erk and phosphoinositide 3-kinase (pi3k)-dependent akt phosphorylation and that activation of both signaling pathways is essential for shh's signaling in muscle cells. However, the effect of shh on akt phosphorylation is more robust than that on mapk/erk, and data suggest that shh influences these pathways in a manner similar to igf-i.	17688959	((HSPs | (PDK1 & PIP3) | PIP3 | (SHH & PIP3)) & !PTCH1)
6	AMP_ATP	ADCY1	-	Nutrients	From Fumia et al, 2013	23922675	(!Nutrients)
7	AMPK	PRKAA1, PRKAA2, PRKAB1, PRKAB2, PRKAG1, PRKAG2, PRKAG3	+	AMP_ATP	From Fumia et al, 2013	23922675	(ATR | HIF1 | AMP_ATP | ATM) & !FGFR3
8	AMPK	PRKAA1, PRKAA2, PRKAB1, PRKAB2, PRKAG1, PRKAG2, PRKAG3	+	ATM	From Fumia et al, 2013 as ATM_ATR	23922675	(ATR | HIF1 | AMP_ATP | ATM) & !FGFR3
9	AMPK	PRKAA1, PRKAA2, PRKAB1, PRKAB2, PRKAG1, PRKAG2, PRKAG3	+	ATR	From Fumia et al, 2013 as ATM_ATR	23922675	(ATR | HIF1 | AMP_ATP | ATM) & !FGFR3
10	AMPK	PRKAA1, PRKAA2, PRKAB1, PRKAB2, PRKAG1, PRKAG2, PRKAG3	-	EGFR	From Fumia et al, 2013 as GF	23922675	(ATR | HIF1 | AMP_ATP | ATM) & !FGFR3
11	AMPK	PRKAA1, PRKAA2, PRKAB1, PRKAB2, PRKAG1, PRKAG2, PRKAG3	-	FGFR3	From Fumia et al, 2013 as GF	23922675	(ATR | HIF1 | AMP_ATP | ATM) & !FGFR3
12	AMPK	PRKAA1, PRKAA2, PRKAB1, PRKAB2, PRKAG1, PRKAG2, PRKAG3	+	HIF1	From Fumia et al, 2013	23922675	(ATR | HIF1 | AMP_ATP | ATM) & !FGFR3
13	Androgen	input	input	0/1	Input of the model		(Androgen)
14	APAF1	APAF1	-	AKT	From Fumia et al, 2013	23922675	((Caspase8 | BAX | p53 | Bak | HSPs) & !Bcl_XL & !BCL2 & !AKT)
15	APAF1	APAF1	+	Bak	From Fumia et al, 2013	23922675	((Caspase8 | BAX | p53 | Bak | HSPs) & !Bcl_XL & !BCL2 & !AKT)
16	APAF1	APAF1	+	BAX	From Fumia et al, 2013	23922675	((Caspase8 | BAX | p53 | Bak | HSPs) & !Bcl_XL & !BCL2 & !AKT)
17	APAF1	APAF1	-	Bcl_XL	From Fumia et al, 2013	23922675	((Caspase8 | BAX | p53 | Bak | HSPs) & !Bcl_XL & !BCL2 & !AKT)
18	APAF1	APAF1	-	BCL2	From Fumia et al, 2013	23922675	((Caspase8 | BAX | p53 | Bak | HSPs) & !Bcl_XL & !BCL2 & !AKT)
19	APAF1	APAF1	+	Caspase8	From Fumia et al, 2013	23922675	((Caspase8 | BAX | p53 | Bak | HSPs) & !Bcl_XL & !BCL2 & !AKT)
20	APAF1	APAF1	-	HSPs	The present studies demonstrate that heat shock protein 90 (hsp90) forms a cytosolic complex with apaf-1 and thereby inhibits the formation of the active complex.	10944114	((Caspase8 | BAX | p53 | Bak | HSPs) & !Bcl_XL & !BCL2 & !AKT)
21	APAF1	APAF1	+	p53	From Fumia et al, 2013	23922675	((Caspase8 | BAX | p53 | Bak | HSPs) & !Bcl_XL & !BCL2 & !AKT)
22	Apoptosis	output	+	Caspase3	Caspase-3 is responsible for apoptosis execution	14585074	(Caspase9 | Caspase8 | Caspase3)
23	Apoptosis	output	+	Caspase8	From Fumia et al, 2013	23922675	(Caspase9 | Caspase8 | Caspase3)
24	Apoptosis	output	+	Caspase9	From Fumia et al, 2013	23922675	(Caspase9 | Caspase8 | Caspase3)
25	AR	AR	+	Androgen	AR activated by binding either of the androgenic hormones, Testosterone, Or dihydrotestosterone in the cytoplasm and then translocating into the nucleus.	27057074	((GLI | EP300 | HSPs | NKX3_1 | EZH2 | NCOA3 | PKC | SMAD | Androgen) & !PTEN & !NCOR1 & !NCOR2 & !MDM2)
26	AR	AR	+	EP300	SRC/p160 coactivators are also able to recruit other coactivators that contain histone acetyl-transferase activity such as Tip60, CBP/p300 (EP300), and p/CAF, which are involved in the acetylation of specific histone residues resulting in chromatin remodeling. 	21956922	((GLI | EP300 | HSPs | NKX3_1 | EZH2 | NCOA3 | PKC | SMAD | Androgen) & !PTEN & !NCOR1 & !NCOR2 & !MDM2)
27	AR	AR	+	EZH2	transcriptional coactivator of AR	23239736	((GLI | EP300 | HSPs | NKX3_1 | EZH2 | NCOA3 | PKC | SMAD | Androgen) & !PTEN & !NCOR1 & !NCOR2 & !MDM2)
28	AR	AR	+	GLI	Gli2 protein can bind to AR and this interaction might define the point of cross-talk between the two signaling pathways.	20420697	((GLI | EP300 | HSPs | NKX3_1 | EZH2 | NCOA3 | PKC | SMAD | Androgen) & !PTEN & !NCOR1 & !NCOR2 & !MDM2)
29	AR	AR	+	HSPs	In an unbound state, The AR complexes with heat-shock, Chaperone and co-chaperone proteins such as HSP90, Which helps to maintain the apo state of the AR in a state competent to bind ligand. The innate stress response induced by castration induces activity of heat-shock proteins (HSP70, HSP90, HSP27) and helps insulate the AR axis from degradation. Overexpression of HSP27 in vivo suppresses apoptosis and is sufficient to confer castrate resistance.	21956922, 2589661	((GLI | EP300 | HSPs | NKX3_1 | EZH2 | NCOA3 | PKC | SMAD | Androgen) & !PTEN & !NCOR1 & !NCOR2 & !MDM2)
30	AR	AR	-	MDM2	These results suggest that phosphorylation-dependent AR ubiquitylation and degradation by Akt require the involvement of Mdm2 E3 ligase activity	12145204	((GLI | EP300 | HSPs | NKX3_1 | EZH2 | NCOA3 | PKC | SMAD | Androgen) & !PTEN & !NCOR1 & !NCOR2 & !MDM2)
31	AR	AR	+	NCOA3	SRC3 (NCOA3) is a preferred coactivator for hormone-activated AR. 	20086010	((GLI | EP300 | HSPs | NKX3_1 | EZH2 | NCOA3 | PKC | SMAD | Androgen) & !PTEN & !NCOR1 & !NCOR2 & !MDM2)
32	AR	AR	-	NCOR1	Unlike coactivators, AR corepressor proteins can form complexes with AR and inhibit the transcription of AR-regulated genes. Any alterations in the expression of these corepressor proteins can also play an important role in the development of AIPC. Two well-characterized AR corepressors are NCoR (nuclear receptor corepressor) and its homolog SMRT (silencing mediator for retinoid and thyroid hormone receptors). Both of these corepressors can recruit histone deacetylases, which promote chromatin packing, resulting in reduced transcriptional activity.	21956922	((GLI | EP300 | HSPs | NKX3_1 | EZH2 | NCOA3 | PKC | SMAD | Androgen) & !PTEN & !NCOR1 & !NCOR2 & !MDM2)
33	AR	AR	-	NCOR2	Unlike coactivators, AR corepressor proteins can form complexes with AR and inhibit the transcription of AR-regulated genes. Any alterations in the expression of these corepressor proteins can also play an important role in the development of AIPC. Two well-characterized AR corepressors are NCoR (nuclear receptor corepressor) and its homolog SMRT (silencing mediator for retinoid and thyroid hormone receptors). Both of these corepressors can recruit histone deacetylases, which promote chromatin packing, resulting in reduced transcriptional activity.	21956922	((GLI | EP300 | HSPs | NKX3_1 | EZH2 | NCOA3 | PKC | SMAD | Androgen) & !PTEN & !NCOR1 & !NCOR2 & !MDM2)
34	AR	AR	+	NKX3_1	NKX3-1 and AR directly regulate each other in a feed-forward regulatory loop.	22083957	((GLI | EP300 | HSPs | NKX3_1 | EZH2 | NCOA3 | PKC | SMAD | Androgen) & !PTEN & !NCOR1 & !NCOR2 & !MDM2)
35	AR	AR	+	PKC	Epidermal growth factor (EGF) increases AR transcriptional activity through PKC-dependent phosphorylation of AR at low levels of androgen in the CWR-R1 prostate cancer cell line derived from the castration-recurrent CWR22 prostate cancer xenograft.	18511414	((GLI | EP300 | HSPs | NKX3_1 | EZH2 | NCOA3 | PKC | SMAD | Androgen) & !PTEN & !NCOR1 & !NCOR2 & !MDM2)
36	AR	AR	-	PTEN	The  interaction  between  PTEN  and  AR  inhibits the AR nuclear translocation and promotes the AR protein degradation.	15205473	((GLI | EP300 | HSPs | NKX3_1 | EZH2 | NCOA3 | PKC | SMAD | Androgen) & !PTEN & !NCOR1 & !NCOR2 & !MDM2)
37	AR	AR	+	SMAD	Smad4, together with SMAD, can interact with the androgen receptor (AR) in the DNA-binding and ligand-binding domains, which may result in the modulation of 5alpha-dihydrotestosterone-induced AR transactivation.	12226080	((GLI | EP300 | HSPs | NKX3_1 | EZH2 | NCOA3 | PKC | SMAD | Androgen) & !PTEN & !NCOR1 & !NCOR2 & !MDM2)
38	AR_ERG	ERG fused	+	AR	AR upregulates ERG via the AR-regulated TMPRSS2 gene promoter. 	23264855	((AR & fused_event) | (AR & fused_event & !NKX3_1))
39	AR_ERG	ERG fused	+	fused_event	ERG can fuse with TMPRSS2 protein to form an oncogenic fusion gene that is commonly found in human prostate cancer, especially in hormone-refractory prostate cancer.	23264855	((AR & fused_event) | (AR & fused_event & !NKX3_1))
40	AR_ERG	ERG fused	-	NKX3_1	NKX3.1 directly binds to TMPRSS2 upstream sequences and negatively regulates the expression of the ERG protooncogene through the TMPRSS2-ERG gene fusion.	24418414	((AR & fused_event) | (AR & fused_event & !NKX3_1))
41	ATM	ATM	+	DNA_Damage	From Fumia et al, 2013	23922675	(DNA_Damage)
42	ATR	ATR	+	DNA_Damage	From Fumia et al, 2013	23922675	(DNA_Damage)
43	ATR	ATR	+	p14ARF	Regulation of NF-kappaB and p53 through activation of ATR and Chk1 by the ARF tumour suppressorInduction of ATR activity in Hs68 E2F1ER cells by endogenous ARF.	15775976	(DNA_Damage)
44	AXIN1	AXIN1	+	GSK3	Signor: Axin, APC and GSK3 bind together in a complex	9601641	(GSK3)
45	BAD	BAD	-	AKT	From Fumia et al, 2013	23922675	(!AKT & !HIF1 & !p90RSK & !RAF & !YWHAZ)
46	BAD	BAD	+	Caspase3	Casp3 cleaves bad at asp-61. In addition, caspases convert bad(l) into a pro-death fragment that resembles the short splice variant.	15231831	(!AKT & !HIF1 & !p90RSK & !RAF & !YWHAZ)
47	BAD	BAD	-	HIF1	From Fumia et al, 2013	23922675	(!AKT & !HIF1 & !p90RSK & !RAF & !YWHAZ)
48	BAD	BAD	-	p90RSK	From Fumia et al, 2013	23922675	(!AKT & !HIF1 & !p90RSK & !RAF & !YWHAZ)
49	BAD	BAD	-	RAF	From Fumia et al, 2013	23922675	(!AKT & !HIF1 & !p90RSK & !RAF & !YWHAZ)
50	BAD	BAD	-	YWHAZ	4-3-3ζ negatively regulates apoptosis by binding and sequestering BAD and BAX in the cytoplasm, effectively preventing activation of proapoptotic Bcl-2 and Bcl-XL.	25266655	(!AKT & !HIF1 & !p90RSK & !RAF & !YWHAZ)
51	Bak	BAK1	+	Caspase8	From Fumia et al, 2013	23922675	(Caspase8)
52	BAX	BAX	-	BCL2	From Fumia et al, 2013	23922675	(!BCL2 & !HIF1 & !YWHAZ & (JNK | HIF1 | p53) & !ETS1)
53	BAX	BAX	-	ETS1	Our results suggest that the interaction between ETS1 and GFI1 facilitates their binding to specific sites on the Bax promoter and represses Bax expression in vivo.	17213822	(!BCL2 & !HIF1 & !YWHAZ & (JNK | HIF1 | p53) & !ETS1)
54	BAX	BAX	-	HIF1	From Fumia et al, 2013	23922675	(!BCL2 & !HIF1 & !YWHAZ & (JNK | HIF1 | p53) & !ETS1)
55	BAX	BAX	+	JNK	From Fumia et al, 2013	23922675	(!BCL2 & !HIF1 & !YWHAZ & (JNK | HIF1 | p53) & !ETS1)
56	BAX	BAX	+	p53	From Fumia et al, 2013	23922675	(!BCL2 & !HIF1 & !YWHAZ & (JNK | HIF1 | p53) & !ETS1)
57	BAX	BAX	-	YWHAZ	4-3-3ζ negatively regulates apoptosis by binding and sequestering BAD and BAX in the cytoplasm, effectively preventing activation of proapoptotic Bcl-2 and Bcl-XL.	25266655	(!BCL2 & !HIF1 & !YWHAZ & (JNK | HIF1 | p53) & !ETS1)
58	Bcl_XL	BCL2L1	+	AR	androgen treatment significantly increased Bcl‐xL expression at mRNA and protein levels via an AR‐dependent mechanism	doi.org/10.1002/pros.20723	(AR & !BAD & !p53)
59	Bcl_XL	BCL2L1	-	BAD	From Fumia et al, 2013	23922675	(AR & !BAD & !p53)
60	Bcl_XL	BCL2L1	-	p53	From Fumia et al, 2013	23922675	(AR & !BAD & !p53)
61	BCL2	BCL2	-	BAD	From Fumia et al, 2013	23922675	((HSPs | NF_kB | RUNX2) & !BAX & !p53 & !DAXX & !BAD)
62	BCL2	BCL2	-	BAX	From Fumia et al, 2013	23922675	((HSPs | NF_kB | RUNX2) & !BAX & !p53 & !DAXX & !BAD)
63	BCL2	BCL2	-	DAXX	Interaction of EAP1/Daxx with ETS1 causes the repression of transcriptional activation of the MMP1 and BCL2 genes.	10698492	((HSPs | NF_kB | RUNX2) & !BAX & !p53 & !DAXX & !BAD)
64	BCL2	BCL2	-	ETS1	Interaction of EAP1/Daxx with ETS1 causes the repression of transcriptional activation of the MMP1 and BCL2 genes.	10698492	((HSPs | NF_kB | RUNX2) & !BAX & !p53 & !DAXX & !BAD)
65	BCL2	BCL2	-	HSPs	HSPs can block the mitochondrial intrinsic pathway of apoptosis by interacting with key proteins. At the mitochondrial level,  HSP90 controls the release of cytochrome c by interacting with Bcl2.	18266962	((HSPs | NF_kB | RUNX2) & !BAX & !p53 & !DAXX & !BAD)
66	BCL2	BCL2	+	NF_kB	From Fumia et al, 2013	23922675	((HSPs | NF_kB | RUNX2) & !BAX & !p53 & !DAXX & !BAD)
67	BCL2	BCL2	-	p53	From Fumia et al, 2013	23922675	((HSPs | NF_kB | RUNX2) & !BAX & !p53 & !DAXX & !BAD)
68	BCL2	BCL2	+	RUNX2	RUNX2 is involved in apoptosis resistance of prostate cancer by modulating expressiopn of BCL2.	HPCHM, 23073173	((HSPs | NF_kB | RUNX2) & !BAX & !p53 & !DAXX & !BAD)
69	beta_catenin	CTNNB1	-	AXIN1	From Fumia et al, 2013	23922675	(!GSK3 & !p53 & !AXIN1 & (EZH2 | YWHAZ))
70	beta_catenin	CTNNB1	+	EZH2	In addition, EZH2 also interacts with various nonhistone proteins such as STAT3, estrogen receptor and beta catenin and thus indirectly serves as a transcriptional activator of their target genes. AKT activates EZH2.	26392259	(!GSK3 & !p53 & !AXIN1 & (EZH2 | YWHAZ))
71	beta_catenin	CTNNB1	-	GSK3	From Fumia et al, 2013	23922675	(!GSK3 & !p53 & !AXIN1 & (EZH2 | YWHAZ))
72	beta_catenin	CTNNB1	-	p53	From Fumia et al, 2013	23922675	(!GSK3 & !p53 & !AXIN1 & (EZH2 | YWHAZ))
73	beta_catenin	CTNNB1	+	YWHAZ	14-3-3zeta facilitates activation of beta-catenin by the survival kinase Akt and colocalizes with activated Akt in intestinal stem cells.	15492215	(!GSK3 & !p53 & !AXIN1 & (EZH2 | YWHAZ))
74	BIRC5	BIRC5	+	HSPs	Survivin co-eluted with the molecular chaperone complex comprising both Hsp90 and Hsp70, in agreement with previous observations.	15218035, 2589661	(HSPs & !p53)
75	BIRC5	BIRC5	-	p53	This study identifies the anti-apoptotic survivin gene as a p53-repressed gene;notably, survivin repression by p53 is shown to be distinct from p53-dependent growth arrest.	11714700	(HSPs & !p53)
76	BMP2	BMP2	+	FGFR3	Furthermore, FGF-2 and FGF-9 increased expression of other osteogenic factors BMP-2 and TGFbeta-1. Meanwhile, blocking endogenous FGF signaling, using a virally transduced dominant-negative FGF receptor (FgfR), resulted in drastically reduced expression of the BMP-2 gene, demonstrating for the first time that endogenous FGF/FgfR signaling is a positive upstream regulator of the BMP-2 gene in calvarial osteoblasts	15780951	(GLI & (TGFBR | FGFR3))
77	BMP2	BMP2	+	GLI	The zinc finger transcription factor gli2 mediates bone morphogenetic protein 2 expression in osteoblasts in response to hedgehog signaling	16880529	(GLI & (TGFBR | FGFR3))
78	BMP2	BMP2	+	TGFBR	We identified PPARg as a missing link between BMP2 and TGFb1 pathways in VSMCs	28467929	(GLI & (TGFBR | FGFR3))
79	BRCA1	BRCA1	+	ATM	From Cho et al., 2016	10866324	((E2F1 | ATM | ATR | (E2F1 & EP300) | (ATM & EP300) | (ATR & EP300)) & !CyclinD & !Bak)
80	BRCA1	BRCA1	+	ATR	From Cho et al., 2016	10866324	((E2F1 | ATM | ATR | (E2F1 & EP300) | (ATM & EP300) | (ATR & EP300)) & !CyclinD & !Bak)
81	BRCA1	BRCA1	-	Caspase3	we demonstrate the cleavage and the consequential downregulation of full-length BRCA1 by caspase-3 during UV-induced apoptosis. Finally, mutation of a caspase-3 specific cleavage site (D/A1154) rendered BRCA1 non-cleavable.	12149654	((E2F1 | ATM | ATR | (E2F1 & EP300) | (ATM & EP300) | (ATR & EP300)) & !CyclinD & !Bak)
82	BRCA1	BRCA1	-	CyclinD	In particular, we have identified ser 632 of brca1 as a cyclin d1/cdk4 phosphorylation site in vitro. Using chromatin immunoprecipitation assays, we observed that the inhibition of cyclin d1/cdk4 activity resulted in increased brca1 dna binding at particular promoters in vivo.	17334399	((E2F1 | ATM | ATR | (E2F1 & EP300) | (ATM & EP300) | (ATR & EP300)) & !CyclinD & !Bak)
83	BRCA1	BRCA1	+	E2F1	From Cho et al., 2016	10660629	((E2F1 | ATM | ATR | (E2F1 & EP300) | (ATM & EP300) | (ATR & EP300)) & !CyclinD & !Bak)
84	BRCA1	BRCA1	+	EP300	ATM-dependent phosphorylation of p300 is required for stabilization of NBS1 proteins in response to DNA damage. (20471956)	20471956	((E2F1 | ATM | ATR | (E2F1 & EP300) | (ATM & EP300) | (ATR & EP300)) & !CyclinD & !Bak)
85	BRCA2	BRCA2	+	ATM	An essential step in homology‐directed repair (HDR) of DNA breaks is the formation of RAD51 nucleofilaments mediated by PALB2–BRCA2	15734731	(ATM & ATR & EP300)
86	BRCA2	BRCA2	+	ATR	An essential step in homology‐directed repair (HDR) of DNA breaks is the formation of RAD51 nucleofilaments mediated by PALB2–BRCA2	15734731	(ATM & ATR & EP300)
87	BRCA2	BRCA2	+	EP300	ATM-dependent phosphorylation of p300 is required for stabilization of NBS1 proteins in response to DNA damage. (20471956)	20471956	(ATM & ATR & EP300)
88	Carcinogen	input	input	0/1	From Fumia et al, 2013	23922675	(Carcinogen)
89	Caspase3	CASP3	+	Caspase8	Triggering of the DISC leads to caspase-8 activation. Active caspase-8 cleaves caspase-3 which, in type I cells, leads to cell death induction	10988287, 21295084	(Caspase8 | Caspase9)
90	Caspase3	CASP3	+	Caspase9	Following autoprocessing in the apoptosome, caspase-9 cleaves and activates caspase-3	9390557, 15657060	(Caspase8 | Caspase9)
91	Caspase8	CASP8	-	cFLAR	Also called c-FLIP. It is directly targeted by AR and is involved in regulation of Fas/FasL mediated apoptosis: plays a role in apoptosis inhibition in androgen dependent prostate cancer cell line. 	15731171	(!cFLAR & FADD)
92	Caspase8	CASP8	+	FADD	From Fumia et al, 2013	23922675	(!cFLAR & FADD)
93	Caspase9	CASP9	-	AKT	Akt phosphorylates Caspase-9, Preventing a caspase cascade leading to cell death.	23732469	((!AKT & CytoC & APAF1 & PTCH1) | (!AKT & BIRC5 & CytoC & APAF1) | (!AKT & BIRC5 & CytoC & APAF1 & PTCH1))
94	Caspase9	CASP9	+	APAF1	From Fumia et al, 2013	23922675	((!AKT & CytoC & APAF1 & PTCH1) | (!AKT & BIRC5 & CytoC & APAF1) | (!AKT & BIRC5 & CytoC & APAF1 & PTCH1))
95	Caspase9	CASP9	+	BIRC5	Survivin (an inhibitor of apoptosis) phosphorylation on thr34 may regulate apoptosis at cell division via an interaction with caspase-9.	11069302	((!AKT & CytoC & APAF1 & PTCH1) | (!AKT & BIRC5 & CytoC & APAF1) | (!AKT & BIRC5 & CytoC & APAF1 & PTCH1))
96	Caspase9	CASP9	+	CytoC	From Fumia et al, 2013	23922675	((!AKT & CytoC & APAF1 & PTCH1) | (!AKT & BIRC5 & CytoC & APAF1) | (!AKT & BIRC5 & CytoC & APAF1 & PTCH1))
97	Caspase9	CASP9	+	PTCH1	Ptc has been shown to function as a dependence receptor; it induces apoptosis in the absence of Shh, whereas its pro-apoptotic activity is blocked in the presence of Shh	19465923	((!AKT & CytoC & APAF1 & PTCH1) | (!AKT & BIRC5 & CytoC & APAF1) | (!AKT & BIRC5 & CytoC & APAF1 & PTCH1))
98	CDH2	CDH2	+	TWIST1	From Cohen et al, 2015	26528548	(TWIST1)
99	cFLAR	CFLAR	+	AKT	in Flobak 2015	26317215	((AKT | AR) & !JNK)
100	cFLAR	CFLAR	+	AR	Also called c-FLIP. It is directly targeted by AR and is involved in regulation of Fas/FasL mediated apoptosis: plays a role in apoptosis inhibition in androgen dependent prostate cancer cell line. 	15731171	((AKT | AR) & !JNK)
101	cFLAR	CFLAR	-	JNK	in Flobak 2015 via ITCH1	26317215	((AKT | AR) & !JNK)
102	CHK1_2	CHEK1, CHEK2	+	ATM	From Fumia et al, 2013	23922675	(ATM & ATR & BRCA1)
103	CHK1_2	CHEK1, CHEK2	+	ATR	From Fumia et al, 2013	23922675	(ATM & ATR & BRCA1)
104	CHK1_2	CHEK1, CHEK2	+	BRCA1	BRCA1, is among several checkpoint mediators that are required for Chk1 activation by ATM and ATR. (PMC3706104)	2447902	(ATM & ATR & BRCA1)
105	COX4I2	COX4I2	+	HIF1	From Fumia et al, 2013	23922675	(HIF1)
106	CyclinB	CCNB1, CCNB2, CCNB3	+	E2F1	From Traynard et al, 2016	27587700	(E2F1 & !p21)
107	CyclinB	CCNB1, CCNB2, CCNB3	-	p21	From Fumia et al, 2013	23922675	(E2F1 & !p21)
108	CyclinB	CCNB1, CCNB2, CCNB3	-	FOXO	From Fumia et al, 2013	23922675	(E2F1 & !p21)
109	CyclinD	CCND1, CCND2, CCND3	-	GLI	From Fumia et al, 2013	23922675	((GLI | TCF | NF_kB) & MYC_MAX & !p21 & !FOXO & !p15 & !GSK3)
110	CyclinD	CCND1, CCND2, CCND3	+	GSK3	From Fumia et al, 2013	23922675	((GLI | TCF | NF_kB) & MYC_MAX & !p21 & !FOXO & !p15 & !GSK3)
111	CyclinD	CCND1, CCND2, CCND3	-	MYC_MAX	From Fumia et al, 2013	23922675	((GLI | TCF | NF_kB) & MYC_MAX & !p21 & !FOXO & !p15 & !GSK3)
112	CyclinD	CCND1, CCND2, CCND3	+	NF_kB	From Fumia et al, 2013	23922675	((GLI | TCF | NF_kB) & MYC_MAX & !p21 & !FOXO & !p15 & !GSK3)
113	CyclinD	CCND1, CCND2, CCND3	+	p15	From Fumia et al, 2013	23922675	((GLI | TCF | NF_kB) & MYC_MAX & !p21 & !FOXO & !p15 & !GSK3)
114	CyclinD	CCND1, CCND2, CCND3	-	p21	From Fumia et al, 2013	23922675	((GLI | TCF | NF_kB) & MYC_MAX & !p21 & !FOXO & !p15 & !GSK3)
115	CyclinD	CCND1, CCND2, CCND3	-	TCF	From Fumia et al, 2013	23922675	((GLI | TCF | NF_kB) & MYC_MAX & !p21 & !FOXO & !p15 & !GSK3)
116	CyclinD	CCND1, CCND2, CCND3	+	AKT	From Fumia et al, 2013	23922675	((GLI | TCF | NF_kB) & MYC_MAX & !p21 & !FOXO & !p15 & !GSK3)
117	CytoC	CYCS	-	Bak	From Fumia et al, 2013	23922675	((Caspase8 | BAX | p53 | Bak) & !Bcl_XL & !BCL2 & !AKT)
118	CytoC	CYCS	+	BAX	From Fumia et al, 2013	23922675	((Caspase8 | BAX | p53 | Bak) & !Bcl_XL & !BCL2 & !AKT)
119	CytoC	CYCS	+	Bcl_XL	From Fumia et al, 2013	23922675	((Caspase8 | BAX | p53 | Bak) & !Bcl_XL & !BCL2 & !AKT)
120	CytoC	CYCS	-	BCL2	From Fumia et al, 2013	23922675	((Caspase8 | BAX | p53 | Bak) & !Bcl_XL & !BCL2 & !AKT)
121	CytoC	CYCS	-	Caspase8	From Fumia et al, 2013	23922675	((Caspase8 | BAX | p53 | Bak) & !Bcl_XL & !BCL2 & !AKT)
122	CytoC	CYCS	+	p53	From Fumia et al, 2013	23922675	((Caspase8 | BAX | p53 | Bak) & !Bcl_XL & !BCL2 & !AKT)
123	CytoC	CYCS	+	ATM	From Fumia et al, 2013	23922675	((Caspase8 | BAX | p53 | Bak) & !Bcl_XL & !BCL2 & !AKT)
124	DAXX	DAXX	-	ATR	Phosphorylation of Daxx by ATM upon DNA damage disrupts the Daxx-Mdm2 interaction and facilitates p53 activation.	23405218	(!ATM & !ATR & !SPOP)
125	DAXX	DAXX	-	SPOP	Phosphorylation of Daxx by ATM upon DNA damage disrupts the Daxx-Mdm2 interaction and facilitates p53 activation.	23405218	(!ATM & !ATR & !SPOP)
126	DAXX	DAXX	-	Carcinogen	SPOP is involved in ubiquitination and proteasomal degradation of DAXX.	26374986	(!ATM & !ATR & !SPOP)
127	DNA_Damage		+	ROS	From Fumia et al, 2013	23922675	((Carcinogen | (Carcinogen & ROS)) & !SPOP)
128	DNA_Damage		+	SPOP	From Fumia et al, 2013	23922675	((Carcinogen | (Carcinogen & ROS)) & !SPOP)
129	DNA_Damage		-	ATM	SPOP, the most commonly mutated gene in primary prostate cancer modulates DNA double strand break (DSB) repair, and SPOP mutation is associated with genomic instability	26374986	((Carcinogen | (Carcinogen & ROS)) & !SPOP)
130	DNA_Repair	output	+	ATR	From Fumia et al, 2013	23922675	(ATM & ATR & (BRCA1 | BRCA2))
131	DNA_Repair	output	+	BRCA1	From Fumia et al, 2013	23922675	(ATM & ATR & (BRCA1 | BRCA2))
132	DNA_Repair	output	+	BRCA2	ZMYM3 facilitates the fine-tuning of BRCA1 interactions with DNA damage sites and chromatin. Consistent with a role in regulating BRCA1 function, ZMYM3 deficiency results in impaired HR repair and genome instability. 	28242625	(ATM & ATR & (BRCA1 | BRCA2))
133	DNA_Repair	output	+	p14ARF	BRCA2 is a mediator of the core mechanism of homologous recombination.	22193408	(ATM & ATR & (BRCA1 | BRCA2))
134	Dsh	DVL1, DVL2, DVL3	+	WNT	From Fumia et al, 2013	23922675	(WNT)
135	E_cadherin	CDH1	+	AR_ERG	ERG overexpression also leads to the loss of E-cadherin expression (a marker of EMT)	doi:10.1038/onc.2015.109	((beta_catenin | AR_ERG) & !Snail & !ERG & !NF_kB & !Slug)
136	E_cadherin	CDH1	+	beta_catenin	Cadherin-11 is localized to a detergent-soluble pool and is associated with both alpha- and beta-catenin	10029089	((beta_catenin | AR_ERG) & !Snail & !ERG & !NF_kB & !Slug)
137	E_cadherin	CDH1	-	ERG	ERG overexpression also leads to the loss of E-cadherin expression (a marker of EMT)	doi:10.1038/onc.2015.109	((beta_catenin | AR_ERG) & !Snail & !ERG & !NF_kB & !Slug)
138	E_cadherin	CDH1	-	NF_kB	From Fumia et al, 2013	23922675	((beta_catenin | AR_ERG) & !Snail & !ERG & !NF_kB & !Slug)
139	E_cadherin	CDH1	-	Slug	From Fumia et al, 2013	23922675	((beta_catenin | AR_ERG) & !Snail & !ERG & !NF_kB & !Slug)
140	E_cadherin	CDH1	-	Snail	From Fumia et al, 2013	23922675	((beta_catenin | AR_ERG) & !Snail & !ERG & !NF_kB & !Slug)
141	E2F1	E2F1, E2F2, E2F3	+	AR	FOXA1 promotes cell growth in an AR-dependent manner. 	26114156	((AR | (FOXA1 & AR) | (ATR & AR) | (ATM & AR)) & !RB1 & !MXI1)
142	E2F1	E2F1, E2F2, E2F3	+	ATM	atm/atr-mediated phosphorylation inhibits the binding and function of skp2 and thus prevents the normal degradation of e2f1	11459832	((AR | (FOXA1 & AR) | (ATR & AR) | (ATM & AR)) & !RB1 & !MXI1)
143	E2F1	E2F1, E2F2, E2F3	+	ATR	atm/atr-mediated phosphorylation inhibits the binding and function of skp2 and thus prevents the normal degradation of e2f1	11459832	((AR | (FOXA1 & AR) | (ATR & AR) | (ATM & AR)) & !RB1 & !MXI1)
144	E2F1	E2F1, E2F2, E2F3	+	FOXA1	FOXA1 promotes cell growth in an AR-dependent manner. 	26114156	((AR | (FOXA1 & AR) | (ATR & AR) | (ATM & AR)) & !RB1 & !MXI1)
145	E2F1	E2F1, E2F2, E2F3	-	MXI1	MXI1 inhibits E2F1 thorugh RB1	27451126	((AR | (FOXA1 & AR) | (ATR & AR) | (ATM & AR)) & !RB1 & !MXI1)
146	E2F1	E2F1, E2F2, E2F3	-	RB1	From Traynard et al, 2016	27587700	((AR | (FOXA1 & AR) | (ATR & AR) | (ATM & AR)) & !RB1 & !MXI1)
147	eEF2	EEF2	-	eEF2K	From Fumia et al, 2013	23922675	(!eEF2K)
148	eEF2K	EEF2K	+	p70S6kab	From Fumia et al, 2013	23922675	(p90RSK | p70S6kab)
149	eEF2K	EEF2K	+	p90RSK	From Fumia et al, 2013	23922675	(p90RSK | p70S6kab)
150	EGF	input	input	0/1	Input of the model		(EGF)
151	EGFR	EGFR	+	Androgen	presence of the AR affect EGF receptor (EGFR)-mediated signaling in response to EGF	"15288768, 19318561
"	((!TGFBR & !FRS2 & !EGFR & !PKC & (ERK | Androgen | EGF)) | (!TGFBR & !FRS2 & (Androgen | EGF)))
152	EGFR	EGFR	+	EGF	After binding of epidermal growth factor (EGF), the EGF receptor (EGFR) becomes autophosphorylated via tyrosine.	10653583	((!TGFBR & !FRS2 & !EGFR & !PKC & (ERK | Androgen | EGF)) | (!TGFBR & !FRS2 & (Androgen | EGF)))
153	EGFR	EGFR	-	EGFR	Initially, an autophosphorylation reaction creates docking sites for several signaling proteins, including a Cbl binding site at tyrosine 1045 of EGFR. Second, EGFR trans-phosphorylates Cbl at a linker domain, which activates an associated ubiquitin ligase activity.	10635327	((!TGFBR & !FRS2 & !EGFR & !PKC & (ERK | Androgen | EGF)) | (!TGFBR & !FRS2 & (Androgen | EGF)))
154	EGFR	EGFR	+	ERK	It is likely that the MAP2 and ERT kinases account for the phosphorylation of the egf receptor at thr669 observed in cultured cells.	10816576	((!TGFBR & !FRS2 & !EGFR & !PKC & (ERK | Androgen | EGF)) | (!TGFBR & !FRS2 & (Androgen | EGF)))
155	EGFR	EGFR	-	FRS2	FRS2 is a major downstream effector that links fibroblast growth factor (FGF) and nerve growth factor receptors with the Ras/mitogen-activated protein kinase signaling cascade	11353842	((!TGFBR & !FRS2 & !EGFR & !PKC & (ERK | Androgen | EGF)) | (!TGFBR & !FRS2 & (Androgen | EGF)))
156	EGFR	EGFR	-	PKC	These data indicate that activation of protein kinase C and subsequent phosphorylation of the EGF receptor at T654 lead to rapid physiological attenuation of EGF receptor signaling.	1860884	((!TGFBR & !FRS2 & !EGFR & !PKC & (ERK | Androgen | EGF)) | (!TGFBR & !FRS2 & (Androgen | EGF)))
157	EGFR	EGFR	-	TGFBR	Our data indicate that a subset of cell lines is dependent on TGF-mediated activation of the EGFR for cell proliferation and strongly suggest that pancreatic tumors expressing high levels of TGF and phosphorylated (activated) EGFR are EGFR-dependent in vitro and in vivo.	16585207	((!TGFBR & !FRS2 & !EGFR & !PKC & (ERK | Androgen | EGF)) | (!TGFBR & !FRS2 & (Androgen | EGF)))
158	EMT		+	AR_ERG	ERG can fuse with TMPRSS2 protein to form an oncogenic fusion gene that is commonly found in human prostate cancer, especially in hormone-refractory prostate cancer.	23264855	(CDH2 & !E_cadherin & !FOXA1)
159	EMT		+	beta_catenin	beta-catenin expression is a marker of EMT	21412939	(CDH2 & !E_cadherin & !FOXA1)
160	EMT		+	CDH2	N-cadherin expression is a marker of EMT	21412939	(CDH2 & !E_cadherin & !FOXA1)
161	EMT		-	E_cadherin	loss of E-cadherin expression is a marker of EMT	21412939	(CDH2 & !E_cadherin & !FOXA1)
162	EMT		-	FOXA1	FoxA1 inhibits cell motility and epithelial-to-mesenchymal transition (EMT) 	23539448	(CDH2 & !E_cadherin & !FOXA1)
163	EP300	EP300	+	AKT	Histone deacetylase inhibitors stimulate active NF-kappaB transcription and cell survival through signaling pathways involving Akt and increased p300 acetyltransferase activity	16926151	(AKT)
164	ERG	ERG	+	ERK	The ability of ERK2 to bind ERG with higher affinity than ETS1 provided a potential molecular explanation for why ERG overexpression drives migration of prostate cells with low levels of RAS/ERK signaling, while ETS1 has a similar function only when RAS/ERK signaling is high. 	25885538	(ERK)
165	ERK	MAPK3, MAPK1	+	MEK1_2	Mapk1 is phosphorylated by map2k1/mek1 and map2k2/mek2	11971971	(RAF | MEK1_2)
166	ERK	MAPK3, MAPK1	+	RAF	From Fumia et al, 2013	23922675	(RAF | MEK1_2)
167	ETS1	ETS1	+	ERK	Signor: MAPK3 (ERK1/2) -> ETS1	11948414	(!p53 & (RTK | ERK))
168	ETS1	ETS1	-	p53	Signor: TP53 -| ETS1	14586398	(!p53 & (RTK | ERK))
169	ETS1	ETS1	+	RTK	Signor: MAPK7 -> ETS1	12048211	(!p53 & (RTK | ERK))
170	ETV1	ETV1	+	ETS1	ETS1 fuses with ETV1 in prostate cancer	19657377	(ETS1 | MEK1_2)
171	ETV1	ETV1	+	MEK1_2	Signor: MEK -> ETV1	20626350	(ETS1 | MEK1_2)
172	EZH2	EZH2	+	AKT	Phosphorylation of EZH2 at Ser21, mediated directly or indirectly by the PI3K-Akt pathway, can switch its function from a Polycomb repressor to a transcriptional coactivator of AR (and potentially other factors).	23239736	(AKT & E2F1 & (ERG | AR_ERG))
173	EZH2	EZH2	+	AR_ERG	The association of EZH2 overexpression and TMPRSS2-ERG fusions is most probably caused by transactivation of the EZH2 promoter by ERG.	26392259	(AKT & E2F1 & (ERG | AR_ERG))
174	EZH2	EZH2	+	E2F1	The pRB-E2F1 pathway tightly regulates EZH2 expression.	14532106	(AKT & E2F1 & (ERG | AR_ERG))
175	EZH2	EZH2	+	ERG	The association of EZH2 overexpression and TMPRSS2-ERG fusions is most probably caused by transactivation of the EZH2 promoter by ERG.	26392259	(AKT & E2F1 & (ERG | AR_ERG))
176	FADD	FADD	-	MAP3K1_3	The results clearly show that fadd phosphorylation at ser194 affects functions both upstream and downstream of the mekk1/mkk7/jnk1 pathway and is closely associated with chemosensitivity in prostate cancer cells	15001534	(PTCH1 | TNFalpha) & !SHH & !MAP3K1_3
177	FADD	FADD	+	PTCH1	Aggregation-induced conformational changes in fas lead to the formation of the death-inducing signalling complex (disc) which involves recruitment of the adaptor protein fadd/mort1 through a homotypic interaction of death domains, present in both the intracellular region of fas and the c-terminus of fadd.	21959933	(PTCH1 | TNFalpha) & !SHH & !MAP3K1_3
178	FADD	FADD	-	SHH	SHH -| PTCH1 -> FADD	14556242, 21959933	(PTCH1 | TNFalpha) & !SHH & !MAP3K1_3
179	FADD	FADD	+	TNFalpha	From Fumia et al, 2013	23922675	(PTCH1 | TNFalpha) & !SHH & !MAP3K1_3
180	FGF	FGF1, FGF2, FGF3, FGF4, FGF5, FGF6, FGF7, FGF8, FGF9, FGF10	input	0/1	Input of the model		(FGF)
181	FGFR3	FGFR3	+	FGF	Crystal structure of a ternary fgf-fgfr-heparin complex reveals a dual role for heparin in fgfr binding and dimerization.	11030354	((FGF | (FGF & RUNX2)) & !FRS2 & !PKC & !TGFBR)
182	FGFR3	FGFR3	-	FRS2	FGF stimulation induces tyrosine phosphorylation of a novel lipid anchored docking protein, termed FRS2	9182757	((FGF | (FGF & RUNX2)) & !FRS2 & !PKC & !TGFBR)
183	FGFR3	FGFR3	-	PKC	Phosphorylation of serine 779 in fibroblast growth factor receptor 1 and 2 by protein kinase c(epsilon) regulates ras/mitogen-activated protein kinase signaling and neuronal differentiationour findings show that in addition to fgfr tyrosine phosphorylation, the phosphorylation of a conserved serine residue, ser(779), can quantitatively control ras/mapk signaling to promote specific cellular responses.	23564461	((FGF | (FGF & RUNX2)) & !FRS2 & !PKC & !TGFBR)
184	FGFR3	FGFR3	+	RUNX2	Runx2 is required for the proliferation of osteoblast progenitors and induces proliferation, at least partly, by regulating Fgfr2 and Fgfr3 expression	30202094	((FGF | (FGF & RUNX2)) & !FRS2 & !PKC & !TGFBR)
185	FGFR3	FGFR3	-	TGFBR	Our data indicate that a subset of cell lines is dependent on TGF-mediated activation of the EGFR for cell proliferation and strongly suggest that pancreatic tumors expressing high levels of TGF and phosphorylated (activated) EGFR are EGFR-dependent in vitro and in vivo.	16585207	((FGF | (FGF & RUNX2)) & !FRS2 & !PKC & !TGFBR)
186	FOS	FOS	+	AR	c-Jun, when complexed with Fos, exhibits a bell-shaped activity on androgen receptor-mediated transactivation which appears to be distinct from c-Jun's transactivation ability	9591784	(ERK | ETS1 | AR)
187	FOS	FOS	+	ERK	From Fumia et al, 2013	23922675	(ERK | ETS1 | AR)
188	FOS	FOS	+	ETS1	The c-ets proto-oncogenes encode transcription factors that cooperate with c-Fos and c-Jun for transcriptional activation.	2114554	(ERK | ETS1 | AR)
189	FOXA1	FOXA1	+	FOXO	Genecard: according to QIAGEN binding sites: FOXO4 -> FOXA1	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FOXA1&keywords=FOXA1	(FOXO)
190	FOXO	FOXO1, FOXO3, FOXO4, FOXO6	-	AKT	From Fumia et al, 2013	23922675	(MAP3K1_3 & JNK & !AKT)
191	FOXO	FOXO1, FOXO3, FOXO4, FOXO6	+	JNK	Braf(v600e) signaling through mitogen-activated protein kinase/extracellular signal-regulated kinase kinase resulted in increased reactive oxygen species levels and c-jun nh(2) terminal kinase-mediated activation of foxo4	20959475	(MAP3K1_3 & JNK & !AKT)
192	FRS2	FRS2	+	EGFR	EGFR and FGFR signaling through FRS2 is subject to negative feedback control by ERK1/2	12974390	(!ERK & !EGFR & FGFR3 & !FRS2 & !TGFBR)
193	FRS2	FRS2	-	ERK	EGFR and FGFR signaling through FRS2 is subject to negative feedback control by ERK1/2	12974390	(!ERK & !EGFR & FGFR3 & !FRS2 & !TGFBR)
194	FRS2	FRS2	+	FGFR3	FGF stimulation induces tyrosine phosphorylation of a novel lipid anchored docking protein, termed FRS2	9182757	(!ERK & !EGFR & FGFR3 & !FRS2 & !TGFBR)
195	FRS2	FRS2	-	FRS2	EGFR and FGFR signaling through FRS2 is subject to negative feedback control by ERK1/2	12974390	(!ERK & !EGFR & FGFR3 & !FRS2 & !TGFBR)
196	FRS2	FRS2	-	TGFBR	TGFbR1 levels are increased when FRS2, an FGFR coactivator, is depleted using shRNA	23200853	(!ERK & !EGFR & FGFR3 & !FRS2 & !TGFBR)
197	fused_event	TMPRSS2	input	0/1	TMPRSS2-Ets gene fusions were identified in prostate cancers where the promoter of transmembrane protease, serine 2 (TMPRSS2) fused with coding sequence of the erythroblastosis virus E26 (Ets) gene family members. TMPRSS2, SLC45A3 and NDRG1 are the androgen induced genes fusioned with ERG. SLC45A3 is also fusioned with ETV1 sometimes but this is outside the scope of the model up to now.	23264855, 20118910	(fused_event)
198	fused_event	SLC45A3	input	0/1	TMPRSS2 and SLC45A3 were the only 5' partner in 78% and 6% of these ERG rearranged cases, respectively. TMPRSS2, SLC45A3 and NDRG1 are the androgen induced genes fusioned with ERG. SLC45A3 is also fusioned with ETV1 sometimes but this is outside the scope of the model up to now.	20118910	(fused_event)
199	fused_event	NDRG1	input	0/1	ERG gene rearrangements and mechanism of rearrangement, as well as rearrangements of TMPRSS2, SLC45A3, and NDRG1, were assessed using fluorescence in situ hybridization (FISH) on prostate cancer samples from 614 patients treated using radical prostatectomy. TMPRSS2, SLC45A3 and NDRG1 are the androgen induced genes fusioned with ERG. SLC45A3 is also fusioned with ETV1 sometimes but this is outside the scope of the model up to now.	20118910	(fused_event)
200	GADD45	GADD45A	+	p53	P53 acetylated at k120 subsequently bound to the promoters of its target apoptotic genes, bax and gadd45, to promote their expression and lead to apoptosis.	23576563	(SMAD | p53)
201	GADD45	GADD45A	+	SMAD	TGF-β-induced activation of p38 MAP kinase is required for TGF-β-induced apoptosis, epithelial-to-mesenchymal transition (EMT), but not growth arrest	12110587	(SMAD | p53)
202	GLI	GLI1, GLI2	+	SMO	The binding of SHH relieves SMO inhibition, leading to activation of the GLI transcription factors	11001584	((WNT | SMO) & !SPOP)
203	GLI	GLI1, GLI2	-	SPOP	Stabilization of speckle-type POZ protein (Spop) by Daz interacting protein 1 (Dzip1) is essential for Gli turnover and the proper output of Hedgehog signaling.	24072710	((WNT | SMO) & !SPOP)
204	GLI	GLI1, GLI2	+	WNT	nt/β-catenin signaling induces expression of an RNA-binding protein, CRD-BP, which, in turn, binds and stabilizes GLI1 mRNA, causing an elevation of GLI1 expression and transcriptional activity.	19887615	((WNT | SMO) & !SPOP)
205	GLUT1	SLC2A1	+	AKT	From Fumia et al, 2013	23922675	((HIF1 | MYC_MAX | AKT) & Nutrients)
206	GLUT1	SLC2A1	+	HIF1	From Fumia et al, 2013	23922675	((HIF1 | MYC_MAX | AKT) & Nutrients)
207	GLUT1	SLC2A1	+	MYC_MAX	From Fumia et al, 2013	23922675	((HIF1 | MYC_MAX | AKT) & Nutrients)
208	GLUT1	SLC2A1	+	Nutrients	GLUT1 transports glucose to begin Glycolysis.	29105798	((HIF1 | MYC_MAX | AKT) & Nutrients)
209	GSH	GSS 	+	MYC_MAX	From Fumia et al, 2013	23922675	(MYC_MAX | NF_kB | p21)
210	GSH	GSS 	+	NF_kB	From Fumia et al, 2013	23922675	(MYC_MAX | NF_kB | p21)
211	GSH	GSS 	+	p21	From Fumia et al, 2013	23922675	(MYC_MAX | NF_kB | p21)
212	GSK3	GSK3A, GSK3B	-	AKT	From Fumia et al, 2013	23922675	(!AKT & !Dsh & MEK1_2 & !mTORC2 & !p90RSK)
213	GSK3	GSK3A, GSK3B	-	Dsh	From Fumia et al, 2013	23922675	(!AKT & !Dsh & MEK1_2 & !mTORC2 & !p90RSK)
214	GSK3	GSK3A, GSK3B	+	MEK1_2	mek1/2 induces tyrosine phosphorylation of gsk-3beta and this cellular event might induce nuclear translocation of gsk-3beta	15020233	(!AKT & !Dsh & MEK1_2 & !mTORC2 & !p90RSK)
215	GSK3	GSK3A, GSK3B	-	mTORC2	From Fumia et al, 2013	23922675	(!AKT & !Dsh & MEK1_2 & !mTORC2 & !p90RSK)
216	GSK3	GSK3A, GSK3B	-	p90RSK	From Fumia et al, 2013	23922675	(!AKT & !Dsh & MEK1_2 & !mTORC2 & !p90RSK)
217	HIF1	HIF1A	-	FOXO	FOXO3a inhibits HIF1-induced apoptosis by stimulating the transcription of CITED2	18158893	(!PHDs & !VHL & !p53 & !FOXO & (HSPs | mTORC1 | mTORC2 | Hypoxia | MYC_MAX))
218	HIF1	HIF1A	+	HSPs	Many of the antivascular effects of Hsp90 inhibitors are likely due to the ability of this class of inhibitors to downregulate HIF activity. We and others have shown that both the HIF-1α and HIF-2α subunits are client proteins for Hsp90 and that chaperone activity is required for HIF stability and function. (PMID:2902748)	2902748	(!PHDs & !VHL & !p53 & !FOXO & (HSPs | mTORC1 | mTORC2 | Hypoxia | MYC_MAX))
219	HIF1	HIF1A	+	Hypoxia	From Fumia et al, 2013	23922675	(!PHDs & !VHL & !p53 & !FOXO & (HSPs | mTORC1 | mTORC2 | Hypoxia | MYC_MAX))
220	HIF1	HIF1A	+	mTORC1	From Fumia et al, 2013	23922675	(!PHDs & !VHL & !p53 & !FOXO & (HSPs | mTORC1 | mTORC2 | Hypoxia | MYC_MAX))
221	HIF1	HIF1A	+	mTORC2	From Fumia et al, 2013	23922675	(!PHDs & !VHL & !p53 & !FOXO & (HSPs | mTORC1 | mTORC2 | Hypoxia | MYC_MAX))
222	HIF1	HIF1A	+	MYC_MAX	From Fumia et al, 2013	23922675	(!PHDs & !VHL & !p53 & !FOXO & (HSPs | mTORC1 | mTORC2 | Hypoxia | MYC_MAX))
223	HIF1	HIF1A	-	p53	From Fumia et al, 2013	23922675	(!PHDs & !VHL & !p53 & !FOXO & (HSPs | mTORC1 | mTORC2 | Hypoxia | MYC_MAX))
224	HIF1	HIF1A	-	PHDs	From Fumia et al, 2013	23922675	(!PHDs & !VHL & !p53 & !FOXO & (HSPs | mTORC1 | mTORC2 | Hypoxia | MYC_MAX))
225	HIF1	HIF1A	-	VHL	From Fumia et al, 2013	23922675	(!PHDs & !VHL & !p53 & !FOXO & (HSPs | mTORC1 | mTORC2 | Hypoxia | MYC_MAX))
226	HSPs	HSP90AA1, HSP90AB1, HSP90B1, HSPA1A, HSPA1B, HSPB1	-	AKT	First, the akt1, akt2, and akt3 isoforms can bind directly to hsp27 and can be found in a complex with p38 mapk, mk2, and hsp27 [98_100]. Second, rane and colleagues showed that akt could phosphorylate hsp27 at ser-82, but not ser-15 or ser-78, in vitro, while co-expression of an active akt mutant and hsp27 in hek cells resulted in hsp27 phosphorylation at the same residue.	19593530	((PKC | FOXA1 | Carcinogen) & !BRCA1 & !E2F1 & !AKT)
227	HSPs	HSP90AA1, HSP90AB1, HSP90B1, HSPA1A, HSPA1B, HSPB1	-	BRCA1	We report here that glucose-regulated protein (GRP)-78, a critical regulator of the unfolded protein response (UPR), is a novel downstream target of BRCA1. We showed that overexpression of wild-type BRCA1 suppressed the expression of GRP78, whereas expression of mutant BRCA1 gene or targeted inhibition of endogenous BRCA1 using small-interfering RNA (siRNA) enhanced GRP78 expression.	18776923	((PKC | FOXA1 | Carcinogen) & !BRCA1 & !E2F1 & !AKT)
228	HSPs	HSP90AA1, HSP90AB1, HSP90B1, HSPA1A, HSPA1B, HSPB1	+	Carcinogen	Although Hsp levels are not informative at the diagnostic level, they are useful biomarkers for carcinogenesis in some tissues	16038406	((PKC | FOXA1 | Carcinogen) & !BRCA1 & !E2F1 & !AKT)
229	HSPs	HSP90AA1, HSP90AB1, HSP90B1, HSPA1A, HSPA1B, HSPB1	-	E2F1	we show that E2F1 represses GRP78/BIP at the transcriptional level, and this requires its DNA binding domain.	18840615	((PKC | FOXA1 | Carcinogen) & !BRCA1 & !E2F1 & !AKT)
230	HSPs	HSP90AA1, HSP90AB1, HSP90B1, HSPA1A, HSPA1B, HSPB1	+	FOXA1	The results showed overexpression of Foxa1 promoted the expression of HSP72, while Foxa1 depletion, induced by antisense oligonucleotides, decreased the expression of HSP72 in MCF-7 cells under normal and heat stress condition.	19486887	((PKC | FOXA1 | Carcinogen) & !BRCA1 & !E2F1 & !AKT)
231	HSPs	HSP90AA1, HSP90AB1, HSP90B1, HSPA1A, HSPA1B, HSPB1	+	PKC	Hsp22 is phosphorylated by protein kinase c (at residues ser(14) and thr(63)) and by p44 mitogen-activated protein kinase (at residues ser(27) and thr(87)). Concerning the possible function of hsp22, no definitive conclusions can be drawn with the available data, although its function might be to bind to and modulate the activity of hsp27.Some Studies claimed that phosphorylation is required for the translocation	22721717	((PKC | FOXA1 | Carcinogen) & !BRCA1 & !E2F1 & !AKT)
232	Hypoxia	input	input	0/1	Input of the model		(Hypoxia)
233	IDH1	IDH1	+	FOXA1	Genecard: Gene has two gene enhancers sequences: GH02I208264 and GH02I208251. SMAD and FOXA1 are part of the genes that could regulate these sequences	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IDH1&keywords=idh1	(SMAD | FOXA1 | mTORC2 | ((SMAD | mTORC2 | FOXA1) & MEK1_2))
234	IDH1	IDH1	+	MEK1_2	IDH1 gene transcription is sterol regulated and activated by SREBP-1a and SREBP-2 in human hepatoma HepG2 cells|evidence that IDH1 may regulate lipogenesis in hepatic cells	12923220	(SMAD | FOXA1 | mTORC2 | ((SMAD | mTORC2 | FOXA1) & MEK1_2))
235	IDH1	IDH1	+	mTORC2	IDH1 gene transcription is sterol regulated and activated by SREBP-1a and SREBP-2 in human hepatoma HepG2 cells|evidence that IDH1 may regulate lipogenesis in hepatic cells	12923220	(SMAD | FOXA1 | mTORC2 | ((SMAD | mTORC2 | FOXA1) & MEK1_2))
236	IDH1	IDH1	+	SMAD	Genecard: Gene has two gene enhancers sequences: GH02I208264 and GH02I208251. SMAD and FOXA1 are part of the genes that could regulate these sequences	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IDH1&keywords=idh1	(SMAD | FOXA1 | mTORC2 | ((SMAD | mTORC2 | FOXA1) & MEK1_2))
237	IKK	CHUK, IKBKB	+	AKT	From Fumia et al, 2013	23922675	((mTORC2 | AKT) & (PKC | TAK1 | ETS1) & !PHDs & !p53)
238	IKK	CHUK, IKBKB	+	ETS1	The transcriptional induction of the IKKalpha gene is positively regulated by binding ETS-1	15469934	((mTORC2 | AKT) & (PKC | TAK1 | ETS1) & !PHDs & !p53)
239	IKK	CHUK, IKBKB	+	mTORC2	From Fumia et al, 2013	23922675	((mTORC2 | AKT) & (PKC | TAK1 | ETS1) & !PHDs & !p53)
240	IKK	CHUK, IKBKB	-	p53	From Fumia et al, 2013. ETS-1 mediated activation of IKKalpha is negatively regulated by p53 binding to ETS-1. 	15469934	((mTORC2 | AKT) & (PKC | TAK1 | ETS1) & !PHDs & !p53)
241	IKK	CHUK, IKBKB	-	PHDs	From Fumia et al, 2013	23922675	((mTORC2 | AKT) & (PKC | TAK1 | ETS1) & !PHDs & !p53)
242	IKK	CHUK, IKBKB	+	PKC	From Fumia et al, 2013	23922675	((mTORC2 | AKT) & (PKC | TAK1 | ETS1) & !PHDs & !p53)
243	IKK	CHUK, IKBKB	+	TAK1	From Fumia et al, 2013	23922675	((mTORC2 | AKT) & (PKC | TAK1 | ETS1) & !PHDs & !p53)
244	Invasion	output	+	beta_catenin	Deletion of β-Catenin in a Pten deleted model of castration-resistant prostate cancer demonstrated it is dispensable for disease progression 	23300485	((CDH2 & SMAD) | (CDH2 & SMAD & EZH2) | beta_catenin)
245	Invasion	output	+	CDH2	N-cadherin is required for TGFbeta induced invasion 	15331629	((CDH2 & SMAD) | (CDH2 & SMAD & EZH2) | beta_catenin)
246	Invasion	output	+	EZH2	EZH2 regulates tumor invasion via the transcriptional repression of the metastasis suppressor RKIP in breast and prostate cancer.	22505648	((CDH2 & SMAD) | (CDH2 & SMAD & EZH2) | beta_catenin)
247	Invasion	output	+	SMAD	TGF-b induces MMP-2 and MMP-9 expresion, using SMAD (among others)	22614218	((CDH2 & SMAD) | (CDH2 & SMAD & EZH2) | beta_catenin)
248	JNK	MAPK8, MAPK9, MAPK10	+	ATM	DNA damage cuased by ROS activates ATM that activates JNK signalling	26791157	((ATM | GADD45 | TAK1 | MAP3K1_3) & !ERK & !p38)
249	JNK	MAPK8, MAPK9, MAPK10	-	ERK	We found that ERK inhibition increased JNK activity. 	16849472	((ATM | GADD45 | TAK1 | MAP3K1_3) & !ERK & !p38)
250	JNK	MAPK8, MAPK9, MAPK10	+	GADD45	From Fumia et al, 2013, via SMAD	23922675	((ATM | GADD45 | TAK1 | MAP3K1_3) & !ERK & !p38)
251	JNK	MAPK8, MAPK9, MAPK10	+	MAP3K1_3	Here we report that MKK4 shows a striking preference for the tyrosine residue (Tyr-185), and MKK7 a striking preference for the threonine residue (Thr-183) in three SAPK1/JNK1 isoforms tested (JNK1 alpha 1, JNK2 alpha 2 and JNK3 alpha 1).	11062067	((ATM | GADD45 | TAK1 | MAP3K1_3) & !ERK & !p38)
252	JNK	MAPK8, MAPK9, MAPK10	-	p38	Ablation of p38alpha results in excessive activation of JNK 	18704119	((ATM | GADD45 | TAK1 | MAP3K1_3) & !ERK & !p38)
253	JNK	MAPK8, MAPK9, MAPK10	+	TAK1	From Fumia et al, 2013, via TGFBR	23922675	((ATM | GADD45 | TAK1 | MAP3K1_3) & !ERK & !p38)
254	JUN	JUN	+	AR	c-Jun, when complexed with Fos, exhibits a bell-shaped activity on androgen receptor-mediated transactivation which appears to be distinct from c-Jun's transactivation ability	9591784	(AR | ETS1 | JNK)
255	JUN	JUN	+	ETS1	The c-ets proto-oncogenes encode transcription factors that cooperate with c-Fos and c-Jun for transcriptional activation.	2114554	(AR | ETS1 | JNK)
256	JUN	JUN	+	JNK	From Fumia et al, 2013	23922675	(AR | ETS1 | JNK)
257	Lactic_acid	LDHA	+	LDHA	From Fumia et al, 2013	23922675	(LDHA)
258	LDHA	LDHA	+	HIF1	From Fumia et al, 2013	23922675	(HIF1 | MYC_MAX | IDH1)
259	LDHA	LDHA	+	IDH1	IDH1 mutation is associated with silencing of the lactate dehydrogenase A (LDHA) gene and decreased glycolysis	24986863	(HIF1 | MYC_MAX | IDH1)
260	LDHA	LDHA	+	MYC_MAX	From Fumia et al, 2013	23922675	(HIF1 | MYC_MAX | IDH1)
261	MAP3K1_3	MAP3K1, MAP3K2, MAP3K3	-	FOS	it was revealed that miR-145-5p was able to suppress EMT by inactivating the c-Jun N-terminal kinase (JNK) signaling pathway in NSCLC cells.	29344125	(RAS & !(FOS | JUN | JNK | p38))
262	MAP3K1_3	MAP3K1, MAP3K2, MAP3K3	-	JNK	Overexpression of MAP3K1 was able to reverse the inhibition of EMT induced by miR-145-5p via the JNK signaling pathway. 	29344125	(RAS & !(FOS | JUN | JNK | p38))
263	MAP3K1_3	MAP3K1, MAP3K2, MAP3K3	-	JUN	it was revealed that miR-145-5p was able to suppress EMT by inactivating the c-Jun N-terminal kinase (JNK) signaling pathway in NSCLC cells.	29344125	(RAS & !(FOS | JUN | JNK | p38))
264	MAP3K1_3	MAP3K1, MAP3K2, MAP3K3	-	p38	Jnk and p38 mapk activation have antagonistic effects in many cases. From a mechanicistic point of view, the p38 mapk pathway can negatively regulate jnk activity at the level of map3ks, either by phosphorylating mlk3 or the tak1 regulatory subunit tab2	20626350	(RAS & !(FOS | JUN | JNK | p38))
265	MAP3K1_3	MAP3K1, MAP3K2, MAP3K3	+	RAS	Activation of ras may lead to two distinct ras-dependent pathways involving either a raf1/mek/mapk module or a mekk/sek/sapk module; jnk/sapk binds to the d domain near the nh2 terminus of mekk1 from approximately residues 6270 (9, 10). Pak1 can phosphorylate mekk1 on serine 67 within its jnk/sapk-binding d domain. Phosphorylation of mekk1 on serine 67 alters the state of the d domain, thereby decreasing its affinity for jnk/sapk. Under these conditions jnk/sapk is not recruited into the mekk1 signaling module.	8649450	(RAS & !(FOS | JUN | JNK | p38))
266	MDM2	MDM2	+	AKT	From Fumia et al, 2013	23922675	(((AKT | p53) & DAXX & !p14ARF & !ATR & !ATM))
267	MDM2	MDM2	-	ATM	From Fumia et al, 2013	23922675	(((AKT | p53) & DAXX & !p14ARF & !ATR & !ATM))
268	MDM2	MDM2	-	ATR	From Fumia et al, 2013	23922675	(((AKT | p53) & DAXX & !p14ARF & !ATR & !ATM))
269	MDM2	MDM2	+	DAXX	The optimal function of mdm2 requires daxx, which stabilizes mdm2 through the deubiquitinase hausp/usp7 and also directly promotes mdm2's ubiquitin ligase activity towards p53.	23405218	(((AKT | p53) & DAXX & !p14ARF & !ATR & !ATM))
270	MDM2	MDM2	-	p14ARF	From Fumia et al, 2013	23922675	(((AKT | p53) & DAXX & !p14ARF & !ATR & !ATM))
271	MDM2	MDM2	+	p53	From Fumia et al, 2013	23922675	(((AKT | p53) & DAXX & !p14ARF & !ATR & !ATM))
272	MED12	MED12	-	GLI	We propose that activated gli3 physically targets med12 in mediator to reverse mediator-dependent suppression of shh target gene (i.e., Gli1 or cyclin d1) transcription.	17000779	(!GLI)
273	MEK1_2	MAP2K1, MAP2K2	+	MAP3K1_3	Signor: MAP3K1,2,3 -> MEK1	11343802	(MAP3K1_3 | RAF | PDK1)
274	MEK1_2	MAP2K1, MAP2K2	+	PDK1	Signor: PDK1 -> MEK2	15175348	(MAP3K1_3 | RAF | PDK1)
275	MEK1_2	MAP2K1, MAP2K2	+	RAF	Signor: RAF -> MEK1, 2	10359597, 8157000	(MAP3K1_3 | RAF | PDK1)
276	Metastasis	output	+	AR_ERG	The overexpression of ERG is one of the key factors in transforming localised, Aggressive cancer into metastatic cancer.	25915839	(Migration & AR_ERG)
277	Metastasis	output	+	ERG	The overexpression of ERG is one of the key factors in transforming localised, Aggressive cancer into metastatic cancer.	25915839	(Migration & AR_ERG)
278	Metastasis	output	+	Migration	From Cohen et al, 2015	26528548	(Migration & AR_ERG)
279	Migration	output	+	AKT	Overall, we have dissected signaling pathways by which Snail may promote cell migration through MAPK signaling or alternatively through PI3K/AKT-Rac1 signaling that involves Snail inhibition of maspin tumor suppressor.	26207671	(((AKT & ERK) | (AKT & ETV1)) & Invasion & EMT)
280	Migration	output	+	AR	The present report, for the first time, indicates that the extra nuclear AR/FlnA/integrin beta 1 complex is the key by which androgen activates signaling leading to cell migration. 	21359179	(((AKT & ERK) | (AKT & ETV1)) & Invasion & EMT)
281	Migration	output	+	EMT	From Cohen et al, 2015	26528548	(((AKT & ERK) | (AKT & ETV1)) & Invasion & EMT)
282	Migration	output	+	ERK	we provide evidence that propagation waves of extracellular signal-related kinase (ERK) mitogen-activated protein kinase activation determine the direction of the collective cell migration. 	29112851	(((AKT & ERK) | (AKT & ETV1)) & Invasion & EMT)
283	Migration	output	+	ETV1	ETV1 overexpressioni n human LNCaP prostate cancer cells increased cell migration.	23076342	(((AKT & ERK) | (AKT & ETV1)) & Invasion & EMT)
284	Migration	output	+	Invasion	From Cohen et al, 2015	26528548	(((AKT & ERK) | (AKT & ETV1)) & Invasion & EMT)
285	mTORC1	MTOR, RICTOR, MLST8, MAPKAP1, DEPTOR, TTI1, TELO2, RPTOR, AKT1S1	+	AKT	Furthermore, pras40 phosphorylation by akt and association with 14-3-3, a cytosolic anchor protein, are crucial for insulin to stimulate mtor. These findings identify pras40 as an important regulator of insulin sensitivity of the akt-mtor pathway and a potential target for the treatment of cancers, insulin resistance and hamartoma syndromes.	17277771	((AKT | (AKT & Rheb)) & !AMPK & !TSC1_2)
286	mTORC1	MTOR, RICTOR, MLST8, MAPKAP1, DEPTOR, TTI1, TELO2, RPTOR, AKT1S1	-	AMPK	AMPK inhibits mTORC1 through two means: first, through phosphorylation of TSC2 to activate its GAP (GTPase-activating protein) activity that converts Rheb into an inactive GDP-bound state, thus switching off mitogenic stimulation of mTORC1 [31], and, secondly, through phosphorylation of raptor at Ser722 and Ser792, which leads to 14-3-3 protein binding and mTORC1 inhibition	23863160	((AKT | (AKT & Rheb)) & !AMPK & !TSC1_2)
287	mTORC1	MTOR, RICTOR, MLST8, MAPKAP1, DEPTOR, TTI1, TELO2, RPTOR, AKT1S1	+	Rheb	These results suggest that Rheb induces alteration in the binding of 4E-BP1 with mTORC1 to regulate mTORC1 activation.	19299511, 19222999	((AKT | (AKT & Rheb)) & !AMPK & !TSC1_2)
288	mTORC1	MTOR, RICTOR, MLST8, MAPKAP1, DEPTOR, TTI1, TELO2, RPTOR, AKT1S1	-	TSC1_2	These findings strongly implicate the tuberin-hamartin tumor suppressor complex as an inhibitor of mtor	12271141	((AKT | (AKT & Rheb)) & !AMPK & !TSC1_2)
289	mTORC2	MTOR, RPTOR, MLST8, PRAS40, DEPTOR, EEF1A1, RICTOR, PRR5	+	AKT	From Fumia et al, 2013	23922675	((!AMPK & RAGS & Rheb) | (AKT & !AMPK & Rheb) | (AKT & !AMPK & RAGS) | (AKT & RAGS & Rheb & !AMPK))
290	mTORC2	MTOR, RPTOR, MLST8, PRAS40, DEPTOR, EEF1A1, RICTOR, PRR5	-	AMPK	From Fumia et al, 2013	23922675	((!AMPK & RAGS & Rheb) | (AKT & !AMPK & Rheb) | (AKT & !AMPK & RAGS) | (AKT & RAGS & Rheb & !AMPK))
291	mTORC2	MTOR, RPTOR, MLST8, PRAS40, DEPTOR, EEF1A1, RICTOR, PRR5	+	RAGS	From Fumia et al, 2013	23922675	((!AMPK & RAGS & Rheb) | (AKT & !AMPK & Rheb) | (AKT & !AMPK & RAGS) | (AKT & RAGS & Rheb & !AMPK))
292	mTORC2	MTOR, RPTOR, MLST8, PRAS40, DEPTOR, EEF1A1, RICTOR, PRR5	+	Rheb	From Fumia et al, 2013	23922675	((!AMPK & RAGS & Rheb) | (AKT & !AMPK & Rheb) | (AKT & !AMPK & RAGS) | (AKT & RAGS & Rheb & !AMPK))
293	MXI1	MXI1	+	HIF1	From Fumia et al, 2013	23922675	(HIF1)
294	MYC	MYC	+	AR_ERG	ERG is a transcriptional factor that directly regulates EZH2, Oncogene c-Myc and tumor suppressor Nkx3.1 and many other targets in prostate cancer. 	doi:10.1158/1538-7445.AM2015-3661	((GLI | ERK | TCF | JUN | FOS | AR_ERG | ERG | NF_kB | SHH) & (mTORC1 | E2F1 | p38) & !HIF1)
295	MYC	MYC	+	E2F1	From Fumia et al, 2013	23922675	((GLI | ERK | TCF | JUN | FOS | AR_ERG | ERG | NF_kB | SHH) & (mTORC1 | E2F1 | p38) & !HIF1)
296	MYC	MYC	+	ERG	ERG is a transcriptional factor that directly regulates EZH2, Oncogene c-Myc and tumor suppressor Nkx3.1 and many other targets in prostate cancer. 	doi:10.1158/1538-7445.AM2015-3661	((GLI | ERK | TCF | JUN | FOS | AR_ERG | ERG | NF_kB | SHH) & (mTORC1 | E2F1 | p38) & !HIF1)
297	MYC	MYC	+	ERK	From Fumia et al, 2013, Phosphorylation of Ser 62 is required for Ras-induced stabilization of Myc, likely mediated through the action of ERK.	23922675, 11018017	((GLI | ERK | TCF | JUN | FOS | AR_ERG | ERG | NF_kB | SHH) & (mTORC1 | E2F1 | p38) & !HIF1)
298	MYC	MYC	+	FOS	From Fumia et al, 2013	23922675	((GLI | ERK | TCF | JUN | FOS | AR_ERG | ERG | NF_kB | SHH) & (mTORC1 | E2F1 | p38) & !HIF1)
299	MYC	MYC	+	GLI	From Fumia et al, 2013	23922675	((GLI | ERK | TCF | JUN | FOS | AR_ERG | ERG | NF_kB | SHH) & (mTORC1 | E2F1 | p38) & !HIF1)
300	MYC	MYC	-	HIF1	From Fumia et al, 2013	23922675	((GLI | ERK | TCF | JUN | FOS | AR_ERG | ERG | NF_kB | SHH) & (mTORC1 | E2F1 | p38) & !HIF1)
301	MYC	MYC	+	JUN	From Fumia et al, 2013	23922675	((GLI | ERK | TCF | JUN | FOS | AR_ERG | ERG | NF_kB | SHH) & (mTORC1 | E2F1 | p38) & !HIF1)
302	MYC	MYC	+	mTORC1	MTORC1 and mTORC2 converge on c-Myc to control metabolic reprogramming in cancer. mTORC1 and mTORC2 conspire to link growth factor receptor–PI3K signaling with c-Myc-dependent metabolic reprogramming by controlling both c-Myc levels and activity 	24856037	((GLI | ERK | TCF | JUN | FOS | AR_ERG | ERG | NF_kB | SHH) & (mTORC1 | E2F1 | p38) & !HIF1)
303	MYC	MYC	+	NF_kB	From Fumia et al, 2013	23922675	((GLI | ERK | TCF | JUN | FOS | AR_ERG | ERG | NF_kB | SHH) & (mTORC1 | E2F1 | p38) & !HIF1)
304	MYC	MYC	+	p38	The jnk pathway is selectively involved in the c-myc-mediated apoptosis and that the apoptotic function of c-myc is directly regulated by jnk pathway through phosphorylation at ser-62 and ser-71.	10551811	((GLI | ERK | TCF | JUN | FOS | AR_ERG | ERG | NF_kB | SHH) & (mTORC1 | E2F1 | p38) & !HIF1)
305	MYC	MYC	+	SHH	In the nucleus, the GLI transcription factors bind DNA and modulate the transcription of a multitude of genes including Fox, Myc, and cyclin D among others that are involved in tissue development, differentiation, epithelial-mesenchymal transition (EMT), and stem cell maintenance	26988232	((GLI | ERK | TCF | JUN | FOS | AR_ERG | ERG | NF_kB | SHH) & (mTORC1 | E2F1 | p38) & !HIF1)
306	MYC	MYC	+	TCF	From Fumia et al, 2013	23922675	((GLI | ERK | TCF | JUN | FOS | AR_ERG | ERG | NF_kB | SHH) & (mTORC1 | E2F1 | p38) & !HIF1)
307	MYC_MAX	MYC, MAX	-	MXI1	From Fumia et al, 2013	23922675	(MYC & !MXI1 & !TGFBR & !SMAD)
308	MYC_MAX	MYC, MAX	+	MYC	From Fumia et al, 2013	23922675	(MYC & !MXI1 & !TGFBR & !SMAD)
309	MYC_MAX	MYC, MAX	-	SMAD	From Fumia et al, 2013	23922675	(MYC & !MXI1 & !TGFBR & !SMAD)
310	MYC_MAX	MYC, MAX	-	TGFBR	From Fumia et al, 2013	23922675	(MYC & !MXI1 & !TGFBR & !SMAD)
311	NCOA3	NCOA3	+	p38	P38 MAPK and JNK can phosphorylate multiple sites on SRC-3, including S505, S543, S860, and S867. Our results suggest that several kinases are important for phosphorylating SRC-3 and enhancing its interaction with DNA-dependent transcription factors and other coactivators.	15383283	(!SPOP & p38)
312	NCOA3	NCOA3	-	SPOP	Mutations in SPOP represent the most common point mutations in primary prostate cancer,with recurrent mutations in SPOP in 6% to 15% of multiple independent cohorts. Wild-type SPOP will bind and promote the degradation of SRC-3,whereas prostate cancer–derived SPOP mutants lose this ability,leading to increased androgen signaling in certain model systems.	24239470	(!SPOP & p38)
313	NCOR1	NCOR1	-	AKT	Akt-induced phosphorylation of N-CoR at serine 1450 contributes to its misfolded conformational dependent loss (MCDL) in acute myeloid leukemia of the M5 subtype. 	23940660	(!AKT)
314	NCOR2	NCOR2	-	AKT	Akt-induced phosphorylation of N-CoR at serine 1450 contributes to its misfolded conformational dependent loss (MCDL) in acute myeloid leukemia of the M5 subtype. 	23940660	(!AKT & !FOXO)
315	NCOR2	NCOR2	-	FOXO	Foxo1 acts to aid displacement of Cs1-associated corepressors (NcoR/Smrt) allowing association of coactivators (Maml1).	18391971	(!AKT & !FOXO)
316	NF_kB	RELA, RELB, REL, NFKB1, NFKB2	+	DNA_Damage	This study particularly focuses on DNA damage-induced NF-κB signaling cascade and its physiological and pathological significance	28626800	((E_cadherin | IKK | DNA_Damage) & (NCOA3 | PIP3 | Snail))
317	NF_kB	RELA, RELB, REL, NFKB1, NFKB2	+	E_cadherin	From Fumia et al, 2013	23922675	((E_cadherin | IKK | DNA_Damage) & (NCOA3 | PIP3 | Snail))
318	NF_kB	RELA, RELB, REL, NFKB1, NFKB2	+	IKK	From Fumia et al, 2013	23922675	((E_cadherin | IKK | DNA_Damage) & (NCOA3 | PIP3 | Snail))
319	NF_kB	RELA, RELB, REL, NFKB1, NFKB2	+	NCOA3	Identification of six functional in vivo SRC-3 phosphorylation sites. Interestingly, all phosphorylation sites are required for coactivation of estrogen and androgen receptors, but not all sites are required for coactivation of NF-kappaB. 	15383283	((E_cadherin | IKK | DNA_Damage) & (NCOA3 | PIP3 | Snail))
320	NF_kB	RELA, RELB, REL, NFKB1, NFKB2	+	PIP3	From Fumia et al, 2013	23922675	((E_cadherin | IKK | DNA_Damage) & (NCOA3 | PIP3 | Snail))
321	NF_kB	RELA, RELB, REL, NFKB1, NFKB2	+	Snail	From Fumia et al, 2013	23922675	((E_cadherin | IKK | DNA_Damage) & (NCOA3 | PIP3 | Snail))
322	NF1	NF1	-	PKC	From Fumia et al, 2013	23922675	(!PKC)
323	NKX3_1	NKX3-1	+	AR	NKX3-1 and AR directly regulate each other in a feed-forward regulatory loop.	22083957	(PKC & AR & !ERG & !AR_ERG)
324	NKX3_1	NKX3-1	-	AR_ERG	Increased expression of ERG or other ETS factors under control of androgen responsive promoter (TMPRSS2) is an inevitable consequence of the fusion events, and it activates transcriptional program that contributes to oncogenesis by upregulating expression of, among others, MYC, EZH2 and SOX9 and repressing NKX3.	25277175	(PKC & AR & !ERG & !AR_ERG)
325	NKX3_1	NKX3-1	-	ERG	Increased expression of ERG or other ETS factors under control of androgen responsive promoter (TMPRSS2) is an inevitable consequence of the fusion events, and it activates transcriptional program that contributes to oncogenesis by upregulating expression of, among others, MYC, EZH2 and SOX9 and repressing NKX3.	25277175	(PKC & AR & !ERG & !AR_ERG)
326	NKX3_1	NKX3-1	+	PKC	The NKX3.1 C154T polymorphism codes for a variant protein that contains an arginine-to-cysteine substitution at amino acid 52 (R52C) adjacent to a protein kinase C phosphorylation site at serine 48	11980664	(PKC & AR & !ERG & !AR_ERG)
327	Nutrients	input	input	0/1	Input of the model		(Nutrients)
328	p14ARF	CDKN2A	+	E2F1	Ectopic expression of a variety of oncogenes such as Ras, cmyc, E1A and E2F1 upregulates p19ARF expression (mice equivalent of p14ARF ) as part of a checkpoint response that limits cell cycle progression in response to hyperproliferative signals	15878778	(E2F1 & MYC_MAX & RAS)
329	p14ARF	CDKN2A	+	MYC_MAX	Ectopic expression of a variety of oncogenes such as Ras, cmyc, E1A and E2F1 upregulates p19ARF expression (mice equivalent of p14ARF ) as part of a checkpoint response that limits cell cycle progression in response to hyperproliferative signals	15878778	(E2F1 & MYC_MAX & RAS)
330	p14ARF	CDKN2A	+	RAS	Ectopic expression of a variety of oncogenes such as Ras, cmyc, E1A and E2F1 upregulates p19ARF expression (mice equivalent of p14ARF ) as part of a checkpoint response that limits cell cycle progression in response to hyperproliferative signals	15878778	(E2F1 & MYC_MAX & RAS)
331	p15	CDKN2B	+	ZBTB17	From Fumia et al, 2013	23922675	(ZBTB17)
332	p21	CDKN1A	-	AKT	From Fumia et al, 2013	23922675	((p53 | SMAD | HIF1 | ZBTB17) & !TERT & !MYC_MAX & !MDM2 & !AKT & !ERK)
333	p21	CDKN1A	-	ERK	Extracellular signal-regulated kinase 2-dependent phosphorylation induces cytoplasmic localization and degradation of p21cip1.	19364816	((p53 | SMAD | HIF1 | ZBTB17) & !TERT & !MYC_MAX & !MDM2 & !AKT & !ERK)
334	p21	CDKN1A	+	HIF1	From Fumia et al, 2013	23922675	((p53 | SMAD | HIF1 | ZBTB17) & !TERT & !MYC_MAX & !MDM2 & !AKT & !ERK)
335	p21	CDKN1A	-	MDM2	Overexpression of hdm2 resulted in a decrease in the level of p21waf1	18292944	((p53 | SMAD | HIF1 | ZBTB17) & !TERT & !MYC_MAX & !MDM2 & !AKT & !ERK)
336	p21	CDKN1A	-	MYC_MAX	From Fumia et al, 2013	23922675	((p53 | SMAD | HIF1 | ZBTB17) & !TERT & !MYC_MAX & !MDM2 & !AKT & !ERK)
337	p21	CDKN1A	+	p53	From Fumia et al, 2013	23922675	((p53 | SMAD | HIF1 | ZBTB17) & !TERT & !MYC_MAX & !MDM2 & !AKT & !ERK)
338	p21	CDKN1A	+	SMAD	From Fumia et al, 2013	23922675	((p53 | SMAD | HIF1 | ZBTB17) & !TERT & !MYC_MAX & !MDM2 & !AKT & !ERK)
339	p21	CDKN1A	-	TERT	From Fumia et al, 2013	23922675	((p53 | SMAD | HIF1 | ZBTB17) & !TERT & !MYC_MAX & !MDM2 & !AKT & !ERK)
340	p21	CDKN1A	+	ZBTB17	From Fumia et al, 2013	23922675	((p53 | SMAD | HIF1 | ZBTB17) & !TERT & !MYC_MAX & !MDM2 & !AKT & !ERK)
341	p38	MAPK14	-	ERK	In addition, immunoblot and immunostaining analysis revealed that phosphorylation of erk was increased by treatment with sb203580;whereas pd98059 increased the phosphorylation of p38, which implies a seesaw-like balance between erk and p38 phosphorylation.	18481201	(MAP3K1_3 & !ERK & !GADD45)
342	p38	MAPK14	+	GADD45	Both phosphorylation of p38 ty323 and the activity of this phosphorylated species are inhibited by binding gadd45alpha, thus preventing these low-treshold signals from activating p38	15735649	(MAP3K1_3 & !ERK & !GADD45)
343	p38	MAPK14	+	MAP3K1_3	We found that mekk1/mekk4 as opposed to ask1, are responsible for trail-induced c-jun nh2-terminal kinase (jnk) or p38 activation,	21152872	(MAP3K1_3 & !ERK & !GADD45)
344	p53	TP53	+	Acidosis	In the case of DNA-damage, phosphorylation of both p53 and Mdm2 by the checkpoint kinases ATM, ATR, Chk1 and Chk2 contributes to the dissociation of the Mdm2-p53 complex, leading to enhanced cellular p53 levels that primarily accumulate in the nucleus.	19879762	((Acidosis | CHK1_2 | p38 | HIF1) & !BCL2 & !MDM2 & !HSPs & !Snail)
345	p53	TP53	-	BCL2	From Fumia et al, 2013	23922675	((Acidosis | CHK1_2 | p38 | HIF1) & !BCL2 & !MDM2 & !HSPs & !Snail)
346	p53	TP53	+	Carcinogen	In the case of DNA-damage, phosphorylation of both p53 and Mdm2 by the checkpoint kinases ATM, ATR, Chk1 and Chk2 contributes to the dissociation of the Mdm2-p53 complex, leading to enhanced cellular p53 levels that primarily accumulate in the nucleus.	19879762	((Acidosis | CHK1_2 | p38 | HIF1) & !BCL2 & !MDM2 & !HSPs & !Snail)
347	p53	TP53	+	CHK1_2	From Fumia et al, 2013	23922675	((Acidosis | CHK1_2 | p38 | HIF1) & !BCL2 & !MDM2 & !HSPs & !Snail)
348	p53	TP53	+	HIF1	From Fumia et al, 2013	23922675	((Acidosis | CHK1_2 | p38 | HIF1) & !BCL2 & !MDM2 & !HSPs & !Snail)
349	p53	TP53	-	HSPs	p53 stabilization depends on the impaired ubiquitination due to both the loss of wt p53 function and the hsp90 association	10557093, 11507088, 12427754, 21460846	((Acidosis | CHK1_2 | p38 | HIF1) & !BCL2 & !MDM2 & !HSPs & !Snail)
350	p53	TP53	-	MDM2	From Fumia et al, 2013	23922675	((Acidosis | CHK1_2 | p38 | HIF1) & !BCL2 & !MDM2 & !HSPs & !Snail)
351	p53	TP53	+	p14ARF	P14/p19 ARF functions by antagonizing MDM2 and thereby stabilizing p53 (refs. 17,18). Thus, loss of p14/p19ARF impairs p53-mediated growth arrest and/or apoptosis in response to activated oncogenes	12091906	((Acidosis | CHK1_2 | p38 | HIF1) & !BCL2 & !MDM2 & !HSPs & !Snail)
352	p53	TP53	+	p38	P38 regulates p53, but also in p53-defective tumor cells rewire their checkpoint response and become dependent in the p38/mk2 pathway in mcf-7 cells, p38 kinase activated p53 more effectively than other members of the ras pathway. p53 and p38 kinase exist in the same physical complex, and co-expression of p38 stabilized p53 protein. In vitro, p38 kinase phosphorylated p53 at ser33 and ser46, a newly identified site.	10581258	((Acidosis | CHK1_2 | p38 | HIF1) & !BCL2 & !MDM2 & !HSPs & !Snail)
353	p70S6kab	RPS6KB1, RPS6KB2	+	mTORC2	From Fumia et al, 2013	23922675	(mTORC2 | PDK1)
354	p70S6kab	RPS6KB1, RPS6KB2	+	PDK1	From Fumia et al, 2013	23922675	(mTORC2 | PDK1)
355	p90RSK	RPS6KA1	+	ERK	From Fumia et al, 2013	23922675	(PDK1 | ERK)
356	p90RSK	RPS6KA1	+	PDK1	From Fumia et al, 2013	23922675	(PDK1 | ERK)
357	PDK1	PDK1	+	HIF1	From Fumia et al, 2013	23922675	(HIF1 | MYC_MAX | PIP3)
358	PDK1	PDK1	+	MYC_MAX	From Fumia et al, 2013	23922675	(HIF1 | MYC_MAX | PIP3)
359	PDK1	PDK1	+	PIP3	From Fumia et al, 2013	23922675	(HIF1 | MYC_MAX | PIP3)
360	PHDs	EGLN1, EGLN2, EGLN3	-	Hypoxia	From Fumia et al, 2013	23922675	(!Hypoxia & ROS)
361	PHDs	EGLN1, EGLN2, EGLN3	+	ROS	From Fumia et al, 2013	23922675	(!Hypoxia & ROS)
362	PI3K	PIK3CA, PIK3CB, PIK3CG, PIK3CD, PIK3R1, PIK3R2, PIK3R3, PIK3R4, PIK3R5, PIK3R6, PIK3C2A, PIK3C2B, PIK3C2G, PIK3C6	+	EGFR	P85alpha promotes nucleolin transcription and subsequently enhances EGFR mRNA stability and EGF-induced malignant cellular transformation.	26918608	(TGFBR | FRS2 | EGFR)
363	PI3K	PIK3CA, PIK3CB, PIK3CG, PIK3CD, PIK3R1, PIK3R2, PIK3R3, PIK3R4, PIK3R5, PIK3R6, PIK3C2A, PIK3C2B, PIK3C2G, PIK3C4	+	FRS2	Activated FRS2α initiates downstream signalling through the RAS–MAPK pathway or the PI3K–AKT pathway	11353842	(TGFBR | FRS2 | EGFR)
364	PI3K	PIK3CA, PIK3CB, PIK3CG, PIK3CD, PIK3R1, PIK3R2, PIK3R3, PIK3R4, PIK3R5, PIK3R6, PIK3C2A, PIK3C2B, PIK3C2G, PIK3C5	+	TGFBR	These studies revealed that PI 3-kinase is associated in vivo with both TGF-_ receptor subtypes and that TGF-_1 stimulation enhances PI 3-kinase activity associated with type I TGF-_ receptor in hASM cells.	9435577	(TGFBR | FRS2 | EGFR)
365	PIP3	PIK3CA	-	p53	From Fumia et al, 2013	23922675	((!p53 & PI3K & !PTEN) | (!p53 & PI3K))
366	PIP3	PIK3CA	+	PI3K	From Fumia et al, 2013	23922675	((!p53 & PI3K & !PTEN) | (!p53 & PI3K))
367	PIP3	PIK3CA	-	PTEN	From Fumia et al, 2013	23922675	((!p53 & PI3K & !PTEN) | (!p53 & PI3K))
368	PKC	PRKD3, PRKD2, PKN3, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PRKCH, PRKCI, PKN1, PKN2, PRKD1, PRKCQ, PRKCZ	+	RTK	From Fumia et al, 2013	23922675	(RTK & WNT)
369	PKC	PRKD3, PRKD2, PKN3, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PRKCH, PRKCI, PKN1, PKN2, PRKD1, PRKCQ, PRKCZ	+	WNT	From Fumia et al, 2013	23922675	(RTK & WNT)
370	Proliferation	output	+	CyclinB	Read-out from model	output	(CyclinB | CyclinD)
371	Proliferation	output	+	CyclinD	Read-out from model	output	(CyclinB | CyclinD)
372	PTCH1	PTCH1	+	GLI	Gli activators bind to gaccaccca motif to regulate transcription of gli1, ptch1, ptch2, hhip1, mycn, ccnd1, ccnd2, bcl2, cflar, foxf1, foxl1, prdm1 (blimp1), jag2, grem1, and follistatin	19860666	(!SHH & GLI)
373	PTCH1	PTCH1	-	SHH	In the responding cell, active Hedgehog binds to its receptor Patched, a 12-pass transmembrane protein, which frees Smoothened, an adjacent 7-pass transmembrane protein, for downstream signaling.Thus, a balance is created by the antagonism of Hedgehog and Patched, whose relative concentrations alternate with respect to each other.	14556242	(!SHH & GLI)
374	PTEN	PTEN	+	FGFR3	Fgfrs phosphorylate pten at tyrosine 240	22891331	((!NF_kB & !Snail & FGFR3 & p53) | (!NF_kB & !Snail & p53))
375	PTEN	PTEN	-	NF_kB	NF-κB activation was necessary and sufficient for inhibition of PTEN expression	14729949	((!NF_kB & !Snail & FGFR3 & p53) | (!NF_kB & !Snail & p53))
376	PTEN	PTEN	+	p53	Transgenic ERG expression in mice blocked Pten/Trp53 alteration-induced decrease of AR expression and downstream luminal epithelial genes	doi: 10.1158/1078-0432.CCR-18-0653	((!NF_kB & !Snail & FGFR3 & p53) | (!NF_kB & !Snail & p53))
377	PTEN	PTEN	-	Snail	Snail prevents the expression of epithelium-specific genes such as PTEN, Muc1, Claudin, and Occludin as well as some nuclear factor receptors (Vitamin D receptor, HNF-1α).	PMC2930904	((!NF_kB & !Snail & FGFR3 & p53) | (!NF_kB & !Snail & p53))
378	RAF	RAF1, ARAF, BRAF	+	EZH2	EZH2 regulates tumor invasion via the transcriptional repression of the Raf-1 kinase inhibitor protein RKIP (PEBP1).	22505648	(!EZH2 & RAS) | (EZH2)
379	RAF	RAF1, ARAF, BRAF	+	RAS	From Fumia et al, 2013	23922675	(!EZH2 & RAS) | (EZH2)
380	RAGS	RAG1, RAG2	-	Hypoxia	From Fumia et al, 2013	23922675	(!Hypoxia & Nutrients)
381	RAGS	RAG1, RAG2	+	Nutrients	From Fumia et al, 2013	23922675	(!Hypoxia & Nutrients)
382	RAS	KRAS, RASA1, HRAS, NRAS	+	EGFR	We conclude that tyr-460 is a site of gap tyrosine phosphorylation by the egf receptor in vitro and likely in vivo. Gap tyr-460 is located immediately c terminal to the second gap sh2 domain, suggesting that its phosphorylation might have a role in regulating protein-protein interactions.	1850098	(EGFR | TGFBR | FRS2 | FGFR3)
383	RAS	KRAS, RASA1, HRAS, NRAS	+	FRS2	Activated FRS2α initiates downstream signalling through the RAS–MAPK pathway or the PI3K–AKT pathway	11353842	(EGFR | TGFBR | FRS2 | FGFR3)
384	RAS	KRAS, RASA1, HRAS, NRAS	+	FGFR3	FGFR3 activates RAS through FRS2	24052019	(EGFR | TGFBR | FRS2 | FGFR3)
385	RAS	KRAS, RASA1, HRAS, NRAS	+	RTK	From Fumia et al, 2013	23922675	(EGFR | TGFBR | FRS2 | FGFR3)
386	RAS	KRAS, RASA1, HRAS, NRAS	+	TGFBR	In addition to the SMAD dependent pathway, [...] RAS [...] are regulated by TGF-β.	29051866	(EGFR | TGFBR | FRS2 | FGFR3)
387	RB1	RB1	-	AMPK	From Traynard et al, 2016	27587700	(!CyclinB & !CyclinD & CHK1_2 & !p53 & !AMPK)
388	RB1	RB1	+	CHK1_2	This study reveals that chk1-mediated phosphorylation of rassf1a, at serine 184, plays an important role in cell-cycle regulation	24197116	(!CyclinB & !CyclinD & CHK1_2 & !p53 & !AMPK)
389	RB1	RB1	-	CyclinB	From Traynard et al, 2016	27587700	(!CyclinB & !CyclinD & CHK1_2 & !p53 & !AMPK)
390	RB1	RB1	-	CyclinD	From Traynard et al, 2016	27587700	(!CyclinB & !CyclinD & CHK1_2 & !p53 & !AMPK)
391	RB1	RB1	-	p53	From Traynard et al, 2016	27587700	(!CyclinB & !CyclinD & CHK1_2 & !p53 & !AMPK)
392	Rheb	RHEB	-	TSC1_2	From Fumia et al, 2013	23922675	(!TSC1_2)
393	ROS	NOX1, NOX2, NOX3, NOX4	+	COX4I2	an up-regulation of COX IV-2 which was accompanied by increased ROS production and necrotic cell death	20734249	((COX4I2 | Hypoxia) & !GSH)
394	ROS	NOX1, NOX2, NOX3, NOX4	-	GSH	Mechanistic study showed that LBL21 induced a rapid depletion of intracellular glutathione (GSH), leading to abnormal ROS accumulation and mitochondrial dysfunction, evident by a decrease in mitochondrial respiration and transmembrane potential	28640251	((COX4I2 | Hypoxia) & !GSH)
395	ROS	NOX1, NOX2, NOX3, NOX4	+	Hypoxia	Thus, hypoxia activates transcription via a mitochondria-dependent signaling process involving increased ROS	9751731	((COX4I2 | Hypoxia) & !GSH)
396	RTK	ERBB2, ERBB3, ERBB4, IGF1R, AATK, ALK, AXL, CSF1R, DDR1, DDR2, FLT1, FLT3, FLT4, INSR, INSRR, KDR, KIT, LMTK2, LMTK3, LTK, MERTK, MET, MST1R, MUSK, NTRK1, NTRK2, NTRK3, PDGFRA, PDGFRB, PTK7, RET, ROR1, ROR2, ROS1, RYK, STYK1, TEK, TIE1, TYRO3	+	EGFR	From Fumia et al, 2013 as GFs	23922675	(EGFR | FGFR3)
397	RTK	ERBB2, ERBB3, ERBB4, IGF1R, AATK, ALK, AXL, CSF1R, DDR1, DDR2, FLT1, FLT3, FLT4, INSR, INSRR, KDR, KIT, LMTK2, LMTK3, LTK, MERTK, MET, MST1R, MUSK, NTRK1, NTRK2, NTRK3, PDGFRA, PDGFRB, PTK7, RET, ROR1, ROR2, ROS1, RYK, STYK1, TEK, TIE1, TYRO3	+	FGFR3	From Fumia et al, 2013 as GFs	23922675	(EGFR | FGFR3)
398	RUNX2	RUNX2	+	ETS1	Runx2 and Ets1 may co-operatively bind to and activate the Fgfr1 promoter	30202094	(!ETS1 & !FOXO & Slug) | (ETS1 & !FOXO)
399	RUNX2	RUNX2	-	FOXO	FOXO1 targets and inhibits RUNX2	21505104	(!ETS1 & !FOXO & Slug) | (ETS1 & !FOXO)
400	RUNX2	RUNX2	+	p38	Mechanistic analysis revealed that the TAK1–MKK3/6–p38 MAPK axis phosphorylated Runx2, promoting its association with the coactivator CREB-binding protein (CBP), which was required to regulate osteoblast genetic programs. These findings reveal an in vivo function for p38β and establish that MAPK signaling is essential for bone formation in vivo.	20551513	(!ETS1 & !FOXO & Slug) | (ETS1 & !FOXO)
401	RUNX2	RUNX2	+	Slug	Slug binds to RUNX2 and SOC9 promoters and may act as a positive and negative transcription regulator.	Uniprot	(!ETS1 & !FOXO & Slug) | (ETS1 & !FOXO)
402	RUNX2	RUNX2	+	SMAD	The Runx2 WT and deletion constructs all physically interact with the BMP2 responsive Smad 4	15573378	(!ETS1 & !FOXO & Slug) | (ETS1 & !FOXO)
403	SHH	SHH	-	ATR	Ptc1(+/-) mice have a defect in the IR-induced activation of the ATR-Chk1 checkpoint signaling pathway	22266795, 18955550	(!BMP2 & !ATR)
404	SHH	SHH	-	BMP2	On the other hand, bmp activity negatively regulates shh transcription and a bmp-shh negative-feedback loop serves to confine shh expression during limb development.	19855020, doi: 10.1242/dev.036418, 25605783	(!BMP2 & !ATR)
405	Slug	SNAI2	-	DAXX	From Fumia et al, 2013	23922675	((TCF | NF_kB) & !DAXX & !p53 & !MDM2)
406	Slug	SNAI2	-	MDM2	From Fumia et al, 2013	23922675	((TCF | NF_kB) & !DAXX & !p53 & !MDM2)
407	Slug	SNAI2	+	NF_kB	From Fumia et al, 2013	23922675	((TCF | NF_kB) & !DAXX & !p53 & !MDM2)
408	Slug	SNAI2	-	p53	From Fumia et al, 2013	23922675	((TCF | NF_kB) & !DAXX & !p53 & !MDM2)
409	Slug	SNAI2	+	TCF	From Fumia et al, 2013	23922675	((TCF | NF_kB) & !DAXX & !p53 & !MDM2)
410	SMAD	SMAD2, SMAD3, SMAD4	-	AR	In the human prostate adenocarcinoma cell line, LNCaP, Ligand-bound AR inhibits TGF-beta transcriptional responses through selectively repressing the binding of SMAD to SBE.	11707452	((TNFalpha | TGFBR) & !AR)
411	SMAD	SMAD2, SMAD3, SMAD4	+	TGFBR	From Fumia et al, 2013	23922675	((TNFalpha | TGFBR) & !AR)
412	SMAD	SMAD2, SMAD3, SMAD4	+	TNFalpha	From Fumia et al, 2013	23922675	((TNFalpha | TGFBR) & !AR)
413	SMO	SMO	-	PTCH1	In the responding cell, active Hedgehog binds to its receptor Patched, a 12-pass transmembrane protein, which frees Smoothened, an adjacent 7-pass transmembrane protein, for downstream signaling.Thus, a balance is created by the antagonism of Hedgehog and Patched, whose relative concentrations alternate with respect to each other.	14556242, 26891329	(!PTCH1 & SHH)
414	SMO	SMO	+	SHH	Binding of Hh to Ptch relieves the repression of Smo, allowing Smo to signal.	16885213	(!PTCH1 & SHH)
415	Snail	SNAI1	-	beta_catenin	From Cohen et al, 2015	26528548	((GLI | NF_kB | SMAD | beta_catenin) & !GSK3 & !p53)
416	Snail	SNAI1	+	GLI	The Hedgehog pathway transcription factor Gli1 induces transformation of epithelial cells via induction of Snail, a repressor of E-cadherin (E-cad). 	1729746	((GLI | NF_kB | SMAD | beta_catenin) & !GSK3 & !p53)
417	Snail	SNAI1	-	GSK3	From Fumia et al, 2013	23922675	((GLI | NF_kB | SMAD | beta_catenin) & !GSK3 & !p53)
418	Snail	SNAI1	+	NF_kB	From Fumia et al, 2013	23922675	((GLI | NF_kB | SMAD | beta_catenin) & !GSK3 & !p53)
419	Snail	SNAI1	+	SMAD	From Fumia et al, 2013	23922675	((GLI | NF_kB | SMAD | beta_catenin) & !GSK3 & !p53)
420	SPOP	SPOP	input	0/1	Input of the model		(SPOP)
421	TAK1	MAP3K7	+	TGFBR	From Fumia et al, 2013	23922675	(TGFBR | TNFalpha)
422	TAK1	MAP3K7	+	TNFalpha	From Fumia et al, 2013	23922675	(TGFBR | TNFalpha)
423	TCF	TCF4, TCF7, TCF7L1, TCF7L2	+	AR_ERG	LEF1 expression is significantly upregulated in ERG-high human prostate cancers.	23913826	((beta_catenin | AR_ERG | ERG) & !TAK1)
424	TCF	TCF4, TCF7, TCF7L1, TCF7L2	+	beta_catenin	From Fumia et al, 2013	23922675	((beta_catenin | AR_ERG | ERG) & !TAK1)
425	TCF	TCF4, TCF7, TCF7L1, TCF7L2	+	ERG	LEF1 expression is significantly upregulated in ERG-high human prostate cancers.	23913826	((beta_catenin | AR_ERG | ERG) & !TAK1)
426	TCF	TCF4, TCF7, TCF7L1, TCF7L2	-	TAK1	From Fumia et al, 2013	23922675	((beta_catenin | AR_ERG | ERG) & !TAK1)
427	TERT	TERT	+	AKT	From Fumia et al, 2013	23922675	((GLI | AKT | HIF1 | MYC_MAX | NF1 | NF_kB | MYC_MAX) & !ZBTB17 & !p53 & !eEF2 & !SMAD)
428	TERT	TERT	-	eEF2	From Fumia et al, 2013	23922675	((GLI | AKT | HIF1 | MYC_MAX | NF1 | NF_kB | MYC_MAX) & !ZBTB17 & !p53 & !eEF2 & !SMAD)
429	TERT	TERT	+	GLI	Recently, it has been shown that GLI1 and GLI2 drive human TERT in colon and prostate cancers	27000000	((GLI | AKT | HIF1 | MYC_MAX | NF1 | NF_kB | MYC_MAX) & !ZBTB17 & !p53 & !eEF2 & !SMAD)
430	TERT	TERT	+	HIF1	From Fumia et al, 2013	23922675	((GLI | AKT | HIF1 | MYC_MAX | NF1 | NF_kB | MYC_MAX) & !ZBTB17 & !p53 & !eEF2 & !SMAD)
431	TERT	TERT	+	MYC_MAX	From Fumia et al, 2013	23922675	((GLI | AKT | HIF1 | MYC_MAX | NF1 | NF_kB | MYC_MAX) & !ZBTB17 & !p53 & !eEF2 & !SMAD)
432	TERT	TERT	+	NF_kB	From Fumia et al, 2013	23922675	((GLI | AKT | HIF1 | MYC_MAX | NF1 | NF_kB | MYC_MAX) & !ZBTB17 & !p53 & !eEF2 & !SMAD)
433	TERT	TERT	+	NF1	From Fumia et al, 2013	23922675	((GLI | AKT | HIF1 | MYC_MAX | NF1 | NF_kB | MYC_MAX) & !ZBTB17 & !p53 & !eEF2 & !SMAD)
434	TERT	TERT	-	p53	From Fumia et al, 2013	23922675	((GLI | AKT | HIF1 | MYC_MAX | NF1 | NF_kB | MYC_MAX) & !ZBTB17 & !p53 & !eEF2 & !SMAD)
435	TERT	TERT	-	SMAD	From Fumia et al, 2013	23922675	((GLI | AKT | HIF1 | MYC_MAX | NF1 | NF_kB | MYC_MAX) & !ZBTB17 & !p53 & !eEF2 & !SMAD)
436	TERT	TERT	-	ZBTB17	From Fumia et al, 2013	23922675	((GLI | AKT | HIF1 | MYC_MAX | NF1 | NF_kB | MYC_MAX) & !ZBTB17 & !p53 & !eEF2 & !SMAD)
437	TGFb	TGFB1, TGFB2, TGFB3	input	0/1	Input of the model		(TGFb)
438	TGFBR	TGFBR1, TGFBR2, TGFBR3	+	HIF1	From Fumia et al, 2013	23922675	((TGFb | (HIF1 & TGFb)) & !MED12)
439	TGFBR	TGFBR1, TGFBR2, TGFBR3	-	MED12	MED12 is in part cytoplasmic where it negatively regulates TGF-βR2 through physical interaction	23178117	((TGFb | (HIF1 & TGFb)) & !MED12)
440	TGFBR	TGFBR1, TGFBR2, TGFBR3	+	TGFb	From Fumia et al, 2013	23922675	((TGFb | (HIF1 & TGFb)) & !MED12)
441	TNFalpha	EDAR, TNFRSF1A, TNFRSF1B, LTBR, TNFRSF4, CD40, FAS, TNFRSF6B, CD27, TNFRSF8, TNFRSF9, TNFRSF10A, TNFRSF10B, TNFRSF10C, TNFRSF10D, TNFRSF11A, TNFRSF11B, TNFRSF12A, TNFRSF13B, TNFRSF13C, TNFRSF14, NGFR, TNFRSF17, TNFRSF18, TNFRSF19, RELT, TNFRSF21, TNFRSF25, EDA2R	input	0/1	Input of the model		(TNFalpha)
442	TSC1_2	TSC1, TSC2	-	AKT	From Fumia et al, 2013	23922675	((AMPK | p53 | HIF1) & !AKT & !ERK & !RAF & !p90RSK)
443	TSC1_2	TSC1, TSC2	+	AMPK	From Fumia et al, 2013	23922675	((AMPK | p53 | HIF1) & !AKT & !ERK & !RAF & !p90RSK)
444	TSC1_2	TSC1, TSC2	-	ERK	From Fumia et al, 2013	23922675	((AMPK | p53 | HIF1) & !AKT & !ERK & !RAF & !p90RSK)
445	TSC1_2	TSC1, TSC2	+	HIF1	From Fumia et al, 2013	23922675	((AMPK | p53 | HIF1) & !AKT & !ERK & !RAF & !p90RSK)
446	TSC1_2	TSC1, TSC2	+	p53	From Fumia et al, 2013	23922675	((AMPK | p53 | HIF1) & !AKT & !ERK & !RAF & !p90RSK)
447	TSC1_2	TSC1, TSC2	-	p90RSK	From Fumia et al, 2013	23922675	((AMPK | p53 | HIF1) & !AKT & !ERK & !RAF & !p90RSK)
448	TSC1_2	TSC1, TSC2	-	RAF	From Fumia et al, 2013	23922675	((AMPK | p53 | HIF1) & !AKT & !ERK & !RAF & !p90RSK)
449	TWIST1	TWIST1	+	beta_catenin	From Cohen et al, 2015	26528548	(Snail | beta_catenin)
450	TWIST1	TWIST1	+	Snail	From Cohen et al, 2015	26528548	(Snail | beta_catenin)
451	VEGF	VEGFA, VEGFB, VEGFC, VEGFD	+	HIF1	From Fumia et al, 2013	23922675	(HIF1 & MYC_MAX)
452	VEGF	VEGFA, VEGFB, VEGFC, VEGFD	+	MYC_MAX	From Fumia et al, 2013	23922675	(HIF1 & MYC_MAX)
453	VHL	VHL	-	Hypoxia	From Fumia et al, 2013	23922675	(!Hypoxia & !ROS)
454	VHL	VHL	-	ROS	From Fumia et al, 2013	23922675	(!Hypoxia & !ROS)
455	WNT	WNT1, WNT2, WNT2B, WNT3, WNT3A, WNT4, WNT5A, WNT5B, WNT6, WNT7A, WNT7B, WNT8A, WNT8B, WNT9A, WNT9B, WNT10A, WNT10B, WNT11, WNT16	+	AR_ERG	ERG overexpression and nuclear translocation activates the activity of Wnt signaling. 	21680704	((((ERG | AR_ERG) & GLI) | ERG | AR_ERG) & !p53)
456	WNT	WNT1, WNT2, WNT2B, WNT3, WNT3A, WNT4, WNT5A, WNT5B, WNT6, WNT7A, WNT7B, WNT8A, WNT8B, WNT9A, WNT9B, WNT10A, WNT10B, WNT11, WNT16	+	ERG	ERG overexpression and nuclear translocation activates the activity of Wnt signaling. 	21680704	((((ERG | AR_ERG) & GLI) | ERG | AR_ERG) & !p53)
457	WNT	WNT1, WNT2, WNT2B, WNT3, WNT3A, WNT4, WNT5A, WNT5B, WNT6, WNT7A, WNT7B, WNT8A, WNT8B, WNT9A, WNT9B, WNT10A, WNT10B, WNT11, WNT16	+	GLI	From Fumia et al, 2013	23922675	((((ERG | AR_ERG) & GLI) | ERG | AR_ERG) & !p53)
458	WNT	WNT1, WNT2, WNT2B, WNT3, WNT3A, WNT4, WNT5A, WNT5B, WNT6, WNT7A, WNT7B, WNT8A, WNT8B, WNT9A, WNT9B, WNT10A, WNT10B, WNT11, WNT16	-	p53	From Fumia et al, 2013	23922675	((((ERG | AR_ERG) & GLI) | ERG | AR_ERG) & !p53)
459	YWHAZ	YWHAZ	+	AR	YWHAZ is under the transcriptional regulation of androgen receptor	22904106	(AR)
460	ZBTB17	ZBTB17	+	AR	From Fumia et al, 2013	23922675	(!MYC_MAX & AR)
461	ZBTB17	ZBTB17	-	MYC_MAX	From Fumia et al, 2013 as MYC	23922675	(!MYC_MAX & AR)
